{
    "2cf03749226444fea30c672c678b3d63": "Neutrophil elastase gene",
    "b0f3562cb2574620ba46ae33c88d65b3": "abnormal involuntary facial movements induced by chronic therapy with classical antipsychotic medications",
    "b7cd2f0a380d4d14b488e20ddf88b204": "antioxidant",
    "733e977ad4f14caf9148b8dbb151fd8c": "antioxidant",
    "c3addb03d57c47208e8a84201cdf7608": "antioxidant",
    "26a83e722adc4516a5e0f6a8f7c8caaa": "antioxidant",
    "b7b765a669484522bfdfa013ced2bc9d": "Srx - dependent modified enzyme",
    "1907600356cb4afeb53267a9f83291d7": "antioxidant",
    "4f34ebb86bd542e3a0ce6e21de3fe86a": "mammalian enzyme",
    "f1d83c49ddc1460baffb741b5751e1c2": "antioxidant",
    "4725ab4959074b2b82db8e9b8383de5d": "antioxidant enzyme",
    "e02be922827e4845bcfa8b7bbd3e8a3e": "thiol - dependent peroxidase",
    "5972815d8210470eb84c3da30f0aa090": "antioxidant",
    "e0afb40c95bf43ecb23eaab63790e3b4": "an enzyme reducing hydrogen peroxide and lipid peroxides",
    "cef4a7fbb56948418ee4895ae79c5294": "Eticlopride",
    "a599caa6467c4126af22518a18e24c41": "DOPA decarboxylase",
    "51cc9b8c720b4a8da80558914feaa7f7": "L - DOPA",
    "9109377696c0452b896a102d8836ded8": "l - DOPA+buspirone",
    "7084fb7065f745f3870b1046a517cc3a": "JL-18",
    "fd218c6955b9465b8d895d3154d58ebb": "L - DOPA / benserazide ) alone or in combination with ( -)-OSU6162",
    "5aad124ed6b3449e87579c5571aa6c64": "ALAAD",
    "d11256fd28f844698bd688152f464ae5": "L - Dopa with peripheral DDC inhibitors",
    "b8c8036eed1c449eb5db1160c25e2ed4": "DOPA",
    "08994280294d46b78596738f2a8bd39a": "tolcapone",
    "56b8eb3015f747f78f3544b919c22c37": "NOTCH3",
    "27c99f3d44a94401b785406bd2f20967": "NOTCH3",
    "fc24f2392a694a878abd703ed179be42": "NOTCH3 gene",
    "23e49b37f14a466999405fd5b5603a3b": "NOTCH3",
    "af0fd3f5bf9540ba8eb2d1ef50fc1544": "Notch3",
    "b2f73e6827624d46a50622245bc0bc8c": "NOTCH3",
    "2c9f414f7a3a499893e29b02c1e7994e": "NOTCH3",
    "966839ca942444edadde10ae73c038bf": "Notch3",
    "33f0175a3dd1410a979d8698198ca39b": "NOTCH3",
    "63bd935131b94b97a6120e16b7ff3249": "NOTCH3",
    "445eaec1f42042ac82afda98668e9da8": "type - I interferon",
    "3d4407ef652d4c23ba87702480b6b50a": "type I IFN",
    "0c569438ed394a3b9e7d3c5ed7abd507": "rituximab",
    "f6eab2419905453ca9b5d473fbd2264f": "IFN signature",
    "255dd5946c024c9287665ddcd2830180": "interferon signature",
    "ee9066e593e54642861b2b0705b2a15a": "interferon signature",
    "78f9bca0ee664b74b0be699e63138b9b": "IFN - signature",
    "b57e6d932c6f403896f80cdbf5c54bf9": "interferon signature",
    "edddbb8cad694d9a8b64e23dfb8292ba": "tyrosine kinase ( TK ) domain of the epidermal growth factor receptor",
    "5cfd33dc4aa142d6ae71e5954d750d83": "epidermal growth factor receptor",
    "7082bcfbfa9a4128987d569a4296cbb7": "epidermal growth factor receptor",
    "98bf14cf3f54411fb46b808b1029b76d": "EGFR",
    "db82e6a831de4a5e9ce53368a088128a": "Epidermal growth factor receptor",
    "4c43e1cef300429f95de389403fe64ce": "EGFR",
    "a19945a83e2d457caf189e2614c1ac05": "epidermal growth factor receptor",
    "8748822cf025490fa5c05702c435c394": "epidermal growth factor receptor",
    "c1fed25571dd435caf919c7770d931d8": "tyrosine kinase inhibitors gefitinib and erlotinib . Nearly 90 % of the EGFR",
    "29f2855a4f1e49cabf0d468c74465cb7": "TK domain of EGFR",
    "2e559521de4543c0bcd36ddc1c47fc44": "epidermal growth factor receptor",
    "ab5ce079faa34a7b97b77449fa304a3f": "LRRK2",
    "9a225d6aa2034d27a58fc2dea42dbe40": "Parkinson 's disease",
    "630e6932bb704bc7a85107087e4dd2ea": "Parkinson 's disease",
    "db39b179aff4498e87b78355b6034f5b": "Parkinson 's disease",
    "5116ed1e5bce44f9a571d769db4825bf": "Parkinson 's disease",
    "93e3e9fa03db483194b1dc67af0aa5af": "Parkinson 's disease",
    "c042537f3aac4a97a4633fcf4c88fc5b": "Parkinson 's disease",
    "2fa17a29be5d4cdb8b61ce90ede60e4a": "Parkinson 's Disease",
    "fe5cca28fd2c430ca12e90e27e78ad75": "Parkinson 's disease",
    "b43e2230834144e38cbeb13c23ffd134": "UUCCUUAAC",
    "47e09473d3cd4d209e14ce17285a816e": "antiparallel spectrin dimers of a tetramer",
    "b37db289ef2948e9b5e75fbc0cbd66bf": "triple alpha - helical coiled coil",
    "341b721c73f64225b0bb8a8e9b4fdbef": "alpha20 - 21/beta1 - 2",
    "159e2ef1d3ca4a3b889fd3fd5ef2acb9": "antiparallel dimer",
    "13e06194c39f4c6793d4a21daead187f": "antiparallel chains that are either force - enhanced or force - independent",
    "6f535f0663104aabbe0325e73769505f": "zipper",
    "98eb6a6cc03a4c00a5f1dbda3e4cead5": "465,000 daltons",
    "0cf3e09ca48743ab8afcd531f7b306e9": "antiparallel dimers",
    "fe7f78eec1aa4f8ebb0a554fd87ebe06": "antiparallel heterodimer",
    "792b104e025543b5b32f47d3bb1b5c44": "antiparallel heterodimer",
    "ab902c462f7c4599b28d61cef6b38d84": "CAFE",
    "4a19f71a111a4c8383421715c8506878": "Diabetic foot osteomyelitis",
    "117440db7a2441f29ff04ebe978b490f": "diabetic foot osteomyelitis",
    "63e453c58aac4f2abda1af843d1f2c50": "diabetic foot osteomyelitis",
    "1b2f285e651143908bfc335257a9a3df": "osteomyelitis",
    "a31831baf7b64813bd2cd193e35c0c77": "diabetic foot osteomyelitis",
    "8c77296f28c84ecf8c27e74782380f94": "X - linked intellectual disability",
    "fecb8a65f2cf49afa3fcf85558513068": "Bazex",
    "a9d9940bee7341a8a218451d58740c07": "Bazex ' syndrome",
    "d451ee65e0e14baaa98a29b68092c5fc": "one of two disorders that have acquired the eponym Bazex syndrome",
    "13712b1db9094ec2bd023d0036495b5d": "Bazex syndrome",
    "cb6b2fd507404102b664bfb2cb1ad97e": "Bazex",
    "17fe85e739194ecda4e790b9d6224dc0": "Bazex syndrome",
    "b5173fd9f31f44a4b8a0a7793cff9f0f": "Bazex syndrome",
    "a02c851b01e7465280df78b10bd835f5": "ventral intermediate thalamic nucleus",
    "f2a831f2a3fc46d1a5b456712da85b80": "globus pallidus internus",
    "2c1bd1c29737403c884ad051c6440ed5": "thalamus DBS",
    "ced1b7f9545a491eadf94408518db9dc": "deep brain structures",
    "6459013464a14756bc918aec303e7b5a": "globus pallidus externus",
    "f1a38a0735d74f2580015f818c2fe6de": "median nerve",
    "0460fb3061fd40ec8e30bfca61c596bb": "bifid median nerve",
    "7bd8a7a1bafe47c3abd747f77a580738": "median nerve",
    "944fef283f4a45c0b0e909cc2f35bb32": "median nerve",
    "7d31ab9e001e4207a7f6499a2b13dd0e": "median nerve",
    "189f48ba6a4e4b66bd3f554956186a5b": "median nerve",
    "e7a2970328e24da5a36fb43bd514f72a": "median nerve",
    "93ad2db0fa834732a6d5f571bafee311": "median nerve",
    "d280d6107fe547dca76066cc0481218e": "hypervascularization in median nerve",
    "3da4e2bccf984afb8212d78a6eab3d6f": "median nerve",
    "75f0878c248e4bbab73420d14772e958": "median nerve",
    "204004adaf394da29332aa0a6d83a243": "plakoglobin",
    "82cb45ef0dce4731bfd7549461b332ab": "cardiac sodium channel gene",
    "fb1932c2568743f8a7e02da6141a50f9": "shortening of pro - metaphase and challenged the nocodazole - triggered mitotic arrest",
    "72198761654a45ae94b82109ef387fe0": "type 1a and b",
    "fcc71128ce954ca0aaa995650ab41118": "FCD",
    "4e97ba94bae54666969f2d440b9221ff": "severe pathologic features",
    "71df3d8251d84f0f8c452651b470a6ec": "Type III",
    "c273e4acf5d244feb5d5fca095c0254f": "FCD type IA ( 3/38 ) , FCD type IB",
    "60e454922314443b97e1f6b1a486c79a": "type IIA",
    "e1524573cdd7436d8cd3549b8bac2c1c": "type I focal cortical dysplasias",
    "77a1eb46e1a443b7a081e53c29ae2ce0": "focal cortical dysplasia",
    "83d14fe95f5740f0a8febe5c79a52938": "mMCDs",
    "1ca976e520c446edbad5c210775e0dc5": "focal cortical dysplasia",
    "b9e939ba9f2c4fa89af0a12d34b058f2": "histologic features",
    "6016428d0f8e493c8cbd0a4863c7c102": "focal cortical dysplasia",
    "06ee6c4a1f9d4cd19afcd49b8dd40d16": "dynamin - related protein Opa1 is localized to the mitochondrial intermembrane space",
    "da99a2b47daf44bb94a87ccf477bf308": "mitochondrial intermembrane space",
    "a304967557fb41c5a6ef72141bdd17f8": "erythrocyte soluble catechol - O - methyltransferase",
    "ca9ef69c3b7343959201d7a68ea4835c": "nitrocatechol catechol - O - methyltransferase",
    "0e5ff4402f1e44c1a1d80868713f9b9f": "catechol - O - methyltransferase",
    "27c5cce16a694b1292f9a384c43beab6": "catechol - O - methyltransferase",
    "6bedca90e5b9429482c8374aa747b8c4": "catechol - O - methyltransferase",
    "250caa665c8448fb98e285306f80e63e": "base - excision repair ( BER ) pathway",
    "d8e2390fcaf54e2d922c90ca3601a0fe": "autosomal dominant",
    "30fd38ce62fe459b88937446ee06bcbb": "autosomal dominant or an autosomal recessive ( AR ) mode of inheritance , GD by an autosomal recessive",
    "2b1cbc97f08540448a7f9be2e32cd04c": "autosomal dominant",
    "4dacfcd587cf4e6f8eed4e508e7a454e": "NSD1",
    "da2112b55fe74ffe80afbc48f42143f7": "NSD1",
    "2cf9e36ee549421b84170a93d439b69d": "NSD1",
    "21b8aedf45d248998d7f1fe63ff3f685": "the nuclear receptor SET domain - containing protein 1",
    "f970b6e9da0e4f42b3418a51e4e4c545": "NSD1",
    "86eebad997b34e70b99bab30bc82e7b6": "NSD1",
    "c0eee31746d343f19dcd03ff0c8496b2": "NSD1",
    "e3fcd872a2a34c279d4633b77cd0d266": "NSD1",
    "1a50ca89e68b478197f95616dd07746e": "NSD1",
    "94ca9bf4ee72459085a2b6464d531562": "SIOD",
    "86b60944892d4aba80de48bd155dcdcb": "SMARCAL1",
    "549c82a2fcb04e38a84c3f7661eeeaf0": "DNA annealing helicase SMARCAL1",
    "4688b81a249a4edd87b46d5ce300cfcf": "Lamp2a",
    "f33d6fecbf754206bd68d7fc7adad530": "lysosome - associated membrane protein type 2a ( lamp2a )",
    "a636a925df634cada0c2d6964688e93a": "lysosome - associated membrane protein type 2a",
    "00514408a6c643d68ffbd2cf86d20e0e": "LAMP2A",
    "231d54cde09548338f239c48ff1fd357": "lysosomal membrane protein ( lamp ) type 2a",
    "2af13c4b405e44c8820036a07143c462": "lysosome - associated membrane protein ( lamp ) type 2a",
    "fdc608c223704b0ca4a61d478dc8dbe2": "Lamp-2a",
    "af4403448ae94c1aa52153c83756e095": "Hsc70",
    "86bd299403624adfa79bf2ac1de79528": "LAMP2A",
    "902996f009de41b18ed94ad607438522": "M3/6",
    "db7adf06a3c547ec93d26a22ee2e1de9": "JNK and AP-1",
    "b7441dc6481f4a8c8ea767fe70d618bb": "p38 kinases",
    "8bdfb8eb6c274633b133fbadf8eaa257": "phosphatase 8",
    "a351b22b820341a499b92892e91315d8": "M3/6",
    "c5027f2833494601b4a79b125f0210f2": "H(2)O(2 )",
    "0e17fa4dc2be4a299e36c5cf49b2fbee": "M3/6",
    "15635a9670bf475ab611b9b1921bbb96": "blepharoconjunctivitis",
    "43b0abaf398b499e989d529cdb03c301": "louse Pthirus pubis",
    "d99ab786d2ec4d17b1540cf721370ef0": "pruritic eyelid margins or unusual blepharoconjunctivitis",
    "ec272621cd3149a5b39e759406ab8844": "neuroendocrine",
    "15bd193287ec4c43b761c54699d4ca55": "Siberia",
    "cb1860ac490e4c2cb4db0aaf636faa83": "histone deacetylase Rpd3",
    "bf4ddb3d39ae4a8ebc75f6c6b7218fbb": "SET domains",
    "549167c35b584704bfc6c93fb4bb55e9": "Meisetz",
    "aa7139e1cfe6425786610c4bf1781099": "Dot1",
    "704744227c8048f0b703848334d6ec87": "catalytic histone methyltransferase SET - domain",
    "94917b06092641a5af6b7e211171d69d": "PRC2",
    "f424eb5bb7c24c5185b12545eb402821": "nucleosome specific",
    "2a976c6394c14d34bced70aaed51880b": "I - SET",
    "6e30dde1ec814c99a87bb332ce35af0c": "lysine 9",
    "3f7b340bb0f840e98a015f2346104288": "SET domain",
    "cdc42c838604450c83009db175c03137": "N - terminal tails",
    "0e9ad5ae9db7422d92338cea8e52e210": "n - SET domain",
    "56ed50d7657b481ea0e2512c19bb0438": "SET7/9",
    "bf7e56357754453da53cec3c83cb7ef2": "PR domain",
    "abd10770670a4418a7c6b4d3caab167b": "DIM-5",
    "d0135b10802e48faa90f81f7c49257ad": "H3-K9",
    "d8dc6dcb02604df98e1a216e74a229fa": "NSD1",
    "d2b96659e02a4db4a080036e2a0c4128": "SET domain",
    "7b483c4cbcd8422c8a975ae0c76fa06c": "Set1B complex",
    "10848a4c98c7472199863319754dae63": "H3-lysine 9",
    "9251d4f613a84dea893231ca779d93d1": "SUV39H1",
    "455d3e2bfca04bab969414f28100925b": "ESC - E",
    "f5801149c94f4f65b82ee302b13c0d29": "conserved SET domain",
    "e57c68a8293d462f9fdab7bb2767c729": "SET domain and ANK repeats",
    "e1caec128d5f4cb4a20159f0430b80d1": "Ash2L",
    "68b1c5deb7d64bd7862645b2ab55c4ff": "SET domain",
    "f7e5563396b64495a72b3ad4feedde3e": "H3K4",
    "0e98ec9fa2fc434f89b5688800607a86": "4 or less",
    "c80dfd34b9334ad1b4191ebe7f406ed0": "high probability of PE",
    "fc7a87328e5b4888b2a342e3a22a865e": "pretest probability",
    "862da8740a8c404c925e5d6116db47e5": "high sensitivity but low specificity",
    "28e8fe6709904ff19ee941b716a6183e": "pretest probability",
    "0bf17a3982cf449e9c3c7f52a98650c2": "For ED patients aged 18+years with suspected PE , CTPE use and yield",
    "a1f4e0c1a4c84385836fb9879b463d73": "Limb - Enhancer Genie",
    "d38d490c5d9f45a0818bec552463879b": "Osteoporosis",
    "837a5b390c774c3fbedff1c210936633": "nuclear factor - \u03baB ligand",
    "ce4f694e2894496cb11f3d96bd206a41": "RANKL",
    "04968485f4484dcc9b26ebe6b289ca4e": "rDNA fragility and genome instability",
    "3d5eec0702a04e5a95da8cdd5d1454d8": "induces skipping of dystrophin exon 51",
    "f67084a71c774272be8ec7fc8baa5f52": "Restless legs syndrome",
    "2e85dc045cba4859af5eff8296aecc96": "RLS / WED",
    "363dd991aef248d6b70acffea567a64a": "Restless legs syndrome",
    "9cce10bf0b6546509cf2de1aba61138e": "Restless legs syndrome",
    "79688e5fa4ba4c6f87957928ba8c86f4": "Restless legs syndrome",
    "bad640c274d449bc9a202b19f0948118": "Restless legs syndrome",
    "017e0735cbc64bf6a05beef4895ac60f": "Restless legs syndrome",
    "c287836b570a4d18b1c683334df92f91": "RLS / WED",
    "3e5986f118e1472abdf00781a69c02a0": "Restless legs syndrome",
    "c1bbf8276dad42dc8e9a68753159154e": "restless legs syndrome",
    "82ca01123a974473aaa47dcd81f47ba5": "restless legs syndrome",
    "b7c3669e630a465892c5b64dbd7a9d82": "restless legs syndrome",
    "fa82e7e496c14296a03d4f2993f80ca8": "RLS / WED",
    "2218c4979008424a9f948a7b71448a42": "restless legs syndrome",
    "289d6353e4064a62a58db9f9192b3eff": "Restless legs syndrome",
    "4f93de9591b34369ba45f43f3f6efb52": "restless legs syndrome",
    "de513d59252e439c8c943b250eba9f14": "restless legs syndrome",
    "aaaca8061b664f71a0d95197ca5ed5a3": "Restless legs syndrome",
    "c13bddb9e37b47c69428caa895cea7ae": "restless legs syndrome",
    "79c7aa35077b48c2acc944b37cf15dca": "restless legs syndrome",
    "bfb32502385540e989c8cc4fc56e54bd": "restless legs syndrome",
    "f69aed865e4f4461b59e86ff393595b6": "Restless legs syndrome",
    "ee27b6a18fa848d0a07f50eae299fa52": "Restless legs syndrome",
    "57c7f4ca7dcc421f8be58691a3878467": "Restless Legs Syndrome",
    "10121cea2cf84ddb98d1d1e853f2f446": "Restless legs syndrome",
    "ad2342b8121d4fafa653d33df74f5afc": "restless legs syndrome",
    "5826e9533ec54fc48c71e5eede6a3e1d": "restless legs syndrome",
    "3117044f9a5c499699d0b54e0b238a5a": "Restless legs syndrome",
    "3dc26f38ab6044c4a7bf30e5bd9852c6": "restless legs syndrome",
    "5dc7b7888b6a4035ae95f669a8d8cfff": "restless legs syndrome",
    "16a25da84839436a89074d9ddedd979f": "Restless Legs Syndrome",
    "9c678887061c48e688347d3c09889e6c": "chromDraw graphical tool",
    "60b2647e211743f5a7666d2124d1686a": "lysosomal",
    "c4ce6c58dde54eb782917fdb75d3caf0": "beta glucocerebrosidase",
    "edb5b97a3a7341bdb6cfc2b80433d4f0": "beta glucocerebrosidase",
    "0f0142c6d85345b6ad31f47e1f7b98d4": "dabigatran",
    "e6ccf71d79284970a5d7adfff0807ec8": "dabigatran",
    "6ce8edfd805842feb2b5ebab77cc5750": "dabigatran",
    "2e849ad8ec784301ae7f31f0261ab00e": "dabigatran",
    "ef28a6cc8b5d472b98e489b35d514e0b": "dabigatran",
    "dc40f38b59fd40f9bfc5fdd3040d8e0c": "dabigatran",
    "8f221782cbec411ab44ab1376d453c6e": "Dabigatran etexilate",
    "f73ca3611d5841e2923535d013cca075": "dabigatran",
    "708d81adb4e44a03ab3e302e8165cec5": "dabigatran",
    "2b3f550f6fc74ff89e6391af6883b958": "dabigatran",
    "d40ca4a4e2a1425fbe7308353258a879": "anticoagulation",
    "f9c27593e5f743369c33b2e1ea8791ae": "dabigatran",
    "d6e9cee2def349948db2eae4577d1aaa": "dabigatran",
    "db97a187c75442e883f177344a687937": "andexanet alfa",
    "1617e42426ba4b0483170d68366da72d": "dabigatran",
    "ed0c4a0629ff46d1b8993188f8a0e5c4": "dabigatran",
    "6c15c6c5007f4bac9ec1454df2719dfa": "dabigatran",
    "6aac3d7c2f5e40e09f41b4cb9a267ef5": "Dabigatran etexilate",
    "3f65fd0a084c4760bb532f7a2c44c223": "dabigatran",
    "8031bea26fff4e0ca71ad6c3b3448396": "dabigatran",
    "2997ce0116fe4da1afc9fa4cdf7e48d6": "dabigatran - induced anticoagulation",
    "92d38fcd3d864c5aa90a01fe0e5787f2": "dabigatran",
    "8e529191f1b142e8bc214514c56ad188": "de Quervain 's disease",
    "28c063ee9b8f48c0a4043216a47ce037": "de Quervain 's disease",
    "0f8cd91547cb45a1a13bab044219379b": "de Quervain 's disease",
    "94956aa6f46c40d6942aab9ac607436f": "negative",
    "ec3c96601d8840c58a8302933740c8a2": "de Quervain 's disease",
    "1f0adb77304f4c188ae40ccb27db4e56": "maintaining calcium homeostasis",
    "9305f4338a854725ab83e9b81c3c35b4": "football",
    "7b02cb46d87c4b849e37b82396d1c3b0": "pneumoperitoneum",
    "89d498b4ba614556a6e601b0a267b76b": "high fever , dry cough and general malaise",
    "f7321b2110b94a3bba595a160b668297": "gene regulatory blocks",
    "e4f9aab09e074c42b56d239bd1ea6bf9": "a common 7SL RNA - derived retroposing monomeric element",
    "7aee0395db2b4a49bbecaa0dd253b366": "the 7SL RNA gene",
    "6fc08188d45a419184053b7f1897cddc": "genome browser",
    "ed3f5c3a0167499384a5f2031c714e92": "centriole",
    "edb15e5cd3594668933fa0a9f6c83206": "Centrosomes",
    "6e490d79b45145a1a5f718e029813107": "proximal lumen",
    "531659cef16e4f2d9ad354129f13c0c8": "at the centrosome",
    "0c06ab7dd90c4dad83de126afa2b4101": "next to the nucleus",
    "08c3aa54125445ca90f9fe4a6632bcf7": "yeast two - hybrid libraries",
    "9ac493dfeaa446d1b53b353bcedbf4eb": "mother centrioles",
    "bc41177a6b044b729aab22fd26e9d225": "Centrosome",
    "edef18590b2a40aea0dfe32bad4780ea": "SAS6 and Cep135/Bld10p",
    "6967a4f88b4e43ab8d32de87626ca820": "antibodies raised against mammalian centrosome components",
    "57611d6d9eaa48c5981f8236cc47fd2e": "CBB and flagella biogenesis",
    "62f547c5c52345068b263ed7bbd85032": "in and outside the centrosome",
    "251f6ff810384420b6df79a29f772ff0": "Na(+)/Ca(2 + ) exchanger",
    "5d94e2adbfb64ff1b3a5b25d968b5828": "Na",
    "78c14f714e4744988b69ad994964895d": "SNP",
    "71fee14086b941aea68a85c15ba9b987": "NCX",
    "f0923f0865c044f8998e18a6c175e105": "NCX",
    "34ac789f67124c93ba8b76414c533807": "ouabain",
    "adf00e4aac1141ad956eda51c049bd02": "mouse cardiac myocytes",
    "3c5acbfea860401088f0e789580bf84b": "NCX",
    "4fe2e279a8224262a6918b198e8b0ed1": "the Na(+)/Ca(2 + ) exchanger",
    "5658da3cc5b84d219d6f6991552febf0": "phenoxy]-5-ethoxyaniline",
    "e77f03a3c71044b98123b465164c6cc7": "Na+/H+ exchanger",
    "62713f6aedae4fbdb697a36a382a3421": "NCX",
    "da32f12980d845719c03c2c03494afe1": "S - methylthiocitrulline",
    "e732552a8ada436c980aa2d6f437c42b": "NCX",
    "1b48a8555b8b48f79655d8c2e14b0f11": "nifedipine",
    "0e4286e02a654fdcade9b809d5a16301": "Na+-Ca2 + exchanger",
    "b64f61ec5c4c4a3383e26a39db26cd14": "LARVA",
    "f6516640f1d44d11963b1679aae29f07": "PU.1",
    "301b11ff9a5742d3b24508da29ebffcd": "eosinophil granulocyte gene",
    "7396c54d3c39402c9b7c126ac3529764": "nuclear factor \u03baB ligand",
    "d8c9be80bd4a48e8898ad993a1531d7f": "TNF family member",
    "ba391f992ee74328aaba8df43265479c": "RANKL",
    "93cde7c0b055488588b25d93e9cddb8a": "NF - kappaB",
    "bd9c8ec49b8446ba9d107c61a8280a06": "nuclear factor - kappaB",
    "6e6d84a65f4e4894b3e184eec8aec0ff": "antibody to RANKL",
    "db3d5700fb404c9d9b22de58652e441b": "androgen",
    "19f21e68fc4946c181d7758601dee5d5": "human RANKL",
    "f239df20b0204fb08398b5c4a58d6f5d": "\u03b2AR - blockers and drugs interfering with RANKL",
    "3e9485482dda405c9488b643f9e2b125": "RANKL",
    "0fbe0e984dcb489284a2e09de385fb16": "nuclear factor - \u03ba\u0392",
    "513ee6b7112740b7afa36d176c0f833f": "RANK - RANKL",
    "66863c5ce37e431c8b6c293c8776da2d": "RANKL",
    "e21623a21a1a48faa65c48b080cfc7fe": "nuclear factor kB",
    "a26bb24d46114aeaa1d54858c6340119": "\u03b1 - synuclein",
    "62d0c93b45ca401ca522395ff2d09c8b": "alpha - synuclein",
    "4687700336544ca7b5e25c199a0d7523": "\u03b1 - synuclein",
    "a4da3f3b9ad440b69aaf79b7d6f6f893": "Alpha - synuclein",
    "1943cdaa336f472f827be07ba6e57bb5": "\u03b1 - Synuclein",
    "69c3caa799bb4990932019ccbabd967e": "synphilin-1",
    "98e46197609848b39e1fb5db6b9f7fa8": "\u03b1 - synuclein",
    "61399ac72d9a4c4397aa7b80ee902d25": "alpha - synuclein",
    "9cf91c000cf144009e50440635f148d1": "alpha - synuclein",
    "e855ce976fe14a41ae526b78066b56f7": "\u03b1 - Synuclein",
    "0a1c02809201488c903f97ee1cd9280f": "Fibrillar \u03b1 - synuclein",
    "344f79431db040ea8cbbb6cb3a1b171a": "Fibrillar \u03b1 - synuclein",
    "5c8a8c9ddaa24aa699e91a1ac4502ebb": "ATP13A2",
    "ec3fbfeea1b541fd86801d3f230fe7ac": "alpha - synuclein",
    "8af93cd51edd4155854b8bc805023cf9": "alpha - synuclein",
    "8cb2d5ed371845bdbc1aef1bc23e2418": "alpha - synuclein",
    "49df234dddfb4af6b70443ee0df3e00d": "Alpha - synuclein",
    "56f2ae49145640039f519cc53fd849b2": "alpha - synuclein",
    "2f91c196e1e14427999116eb471acf92": "TDP-43",
    "5d3ed014bc4046eda811724747a7aa23": "Alpha - synuclein",
    "2270a17d1c8b4ecba24ad304bcb2f5ad": "Human \u03b1 - synuclein",
    "7206b07769574e8793fa79da4f2aab29": "Alpha - synuclein",
    "84268ced61744024a40b6f8d2316d275": "alpha - Synuclein and ubiquitin",
    "4a93e831ea4b4c5fb6f059f0b2cca5be": "caspase - cleaved TDP-43",
    "c30df28116514592a00694925f3d7a42": "alpha - synuclein",
    "cf97c5fcf3d94305a47f705ecb7271f5": "Alpha - synuclein",
    "8a982cf38c2d47b0b8b6fa7d85dfa679": "synphilin-1",
    "770cdf4bff11453d9e85c2d6c5857367": "\u03b1 - syn",
    "ef3220cd0654492584edc7a94fda2c33": "alpha - synuclein",
    "4504ae5e0d41435984b259c276b8cf7f": "\u03b1 - Synuclein",
    "74f41b3184c1456789908466697ca25d": "alpha - synuclein",
    "d5f8f2fee1f04e1ca38a7afa3aca1b32": "\u03b1 - synuclein",
    "d8e3b9a07469427db951cf2a0ae90c0f": "alpha - Syn",
    "d46479c4ece34bc181a6026e994a86e9": "alpha - synuclein",
    "91fa2b5f1bc346b9a724636caadd7ff3": "alpha - synuclein",
    "d74834afd23a4192b6b88ed137c2ea87": "alpha - synuclein",
    "25ed7d746b414134b9454c0b72df2885": "alpha - synuclein protein",
    "8d63de36b0444dddb8a5c62a74c27315": "Alpha - synuclein",
    "dcbeada03bcb4f4d8ba89ab6cff60b0d": "\u03b1 - Synuclein",
    "bbcdadd974b7443eae14570e28207e80": "\u03b1 - Synuclein",
    "a9b0e00be51344dca4d96c64bd53c6e7": "beta - spectrin",
    "dd51992abbdc4acdbe0da902d5a6786a": "alpha - synuclein",
    "842999d9925347eca644cb9699a36b65": "alpha - synuclein",
    "85f89f3d85be487db0659a2ec7d6968f": "alpha - synuclein protein",
    "02aedd384e0844e18fd9364151f02926": "\u03b1 - Synuclein",
    "b2abafc04b054092acd209ab0f099725": "neurotransmitter GABA",
    "0886b5bfb37f4842a63d965014d3b9fa": "Prader - Willi syndrome",
    "03aa34b985ac43f7b28e110d51d52e44": "Prader - Willi syndrome",
    "4f919178eb6f4d1f95f762a80274308e": "Prader - Willi syndrome",
    "8b979d0ca3aa47dbbd35ea426dc78be3": "Prader - Willi syndrome",
    "945a16348aeb4d0eb69c3c58a1a53610": "loss - of - function mutations",
    "75877e12360244ecaad667bb28813b4c": "SLC9A6",
    "c2555b0ac9b54ee5827e62554a179317": "SLC9A6",
    "1c8d376fd6a5424aa7f69d6d2222e256": "SLC9A6",
    "b926d6e0091141cb9a74f555ced0e3ae": "SLC9A6",
    "7bc7d50257d34f87ab4fb5cf15488ef8": "SLC9A6",
    "215553b82687403fb1ece277d1cece01": "SLC9A6",
    "6a1f2f3255d649e7b1cd4683b639e954": "SLC9A6",
    "9bcff955534e462aad930acfdb1fef0c": "SLC9A6",
    "9051b478ee6f41f98b58e2be06353573": "SLC9A6",
    "3b4719a2c58345f4acb8bac904ff6d5c": "SLC9A6",
    "ddf1ff17a2ea4e5088dd93222e4a7289": "SLC9A6",
    "c411a46cdf7345d8a5ed11e24dde3a88": "SLC9A6",
    "d941cbf53efb4218a8348c71b146a2d2": "SLC9A6",
    "66ed19703ab9429588260046aacc2ac1": "FHL1",
    "141c4f0d6d4d4916a34c9dae06adcc8a": "SLC9A6",
    "d77f93b7ab7a49efbb741987986a7418": "Chediak - Higashi Syndrome",
    "f0c6e9007d0640d4afd5fdb4f2199ae1": "loss of NK cell degranulation and cytotoxicity",
    "8283a8628bfe440b908b5fe0ef0625ea": "Chediak - Higashi syndrome",
    "29efec5e73924fffae1401b29f98e261": "Chediak - Higashi syndrome",
    "d6994d74aee440879b8c68ca849fa9db": "Chediak - Higashi syndrome",
    "40cc928d16714c79baadc63e10e82c30": "Chediak - Higashi syndrome",
    "502fe409d7d94564b083ec1308dc8740": "Chediak - Higashi syndrome",
    "23bd86de677a400e8ee3c4a56c6f39e1": "Chediak- Higashi syndrome",
    "0a6e92fd38084c6080d63bdcfc202f5b": "Chediak - Higashi syndrome",
    "951b2519bc4f461191fcb2cfbdb346b4": "Chediak - Higashi syndrome",
    "ec77a7e4587a4882bcd45d55cf28a629": "Chediak - Higashi syndrome",
    "3ca8e7b15fbb4a1fac7c75a96d9043d5": "Chediak - Higashi Syndrome",
    "2d94618b5f9d418e967e8d0aff6598aa": "Chediak - Higashi syndrome",
    "6a6c0c5ae87d4079ad03b0e1d5ecdd40": "Chediak - Higashi syndrome",
    "ba84f91cf9b6461d9ee02be446bcdffc": "CHS",
    "5c2891c2c9d1421e9802096802dc5dda": "Chediak - Higashi syndrome",
    "08de58bba59d48acbc705a1f43e25d57": "Chediak - Higashi syndrome",
    "5f58316e6f574ba2a0272fb6ad55acac": "Chediak - Higashi syndrome",
    "48de9af03ef14e918760efaeb35e7f7b": "Chediak - Higashi syndrome",
    "7b387c3302ca4a718ed588d6618acea4": "Chediak - Higashi syndrome",
    "45ce4033bb5f467ea111a26e625b6379": "Chediak - Higashi syndrome",
    "bf90e54a60234266b05dd70fed882e86": "clearance",
    "a41b67e4e4004aa6a155ea9bb5d45fc4": "men and women",
    "7996bd8205754c248b98cf55204c7a56": "women is not only more common",
    "3a09c991f94d49ac9f85560e9ef63b8f": "women",
    "4dea6626ae0746408e89bcdce7226c6f": "men",
    "33ce31f2b31e434a8646df96cc8b9daa": "women",
    "b3aff0ff72834de8bbd3a3ca13a60532": "women and men",
    "caa2671c22184059b24fc1b2ad609ea4": "women",
    "69fcba3609b5468a8fd5f00111a3756d": "men",
    "dd55ff8b09a7433aa467295dae5b0c62": "Men",
    "08cbe847c7dd46e685e5a9239d668120": "women",
    "f85c2449871b49c598f41e1f233256be": "enzyme",
    "e6f62469f2c6413a8f4161544dcb6f44": "autosomal dominant pattern of inheritance",
    "52cd8f90006a41c999627c367f252ff3": "mainly by the autosomal dominant type",
    "d33ad3bcc29749269c3aa087a59610af": "an expansion of a CTG triplet repeat in the DMPK gene",
    "3dff550077ca471a8137430b2d11722c": "clinically and genetically heterogeneous neuromuscular disorder",
    "2129b866927d4b40aa157a6635c07254": "a CCTG tetranucleotide repeat expansion",
    "9bd63fef68a04a01ba5834b3974db52c": "INteractive Codon usage Analysis",
    "440cb51fb1df468ebee4c3925fef9da6": "S129",
    "7161d325e39f4f4884391fb5e3adb5db": "serine 129",
    "19423394bc5f47e9b3ab1ee3b8cca638": "serine 129",
    "36caa3ccb74340beb0182b812e4fbc13": "Mycobacterium tuberculosis",
    "62a1183be31d4c208669a471c24c419c": "TB",
    "4edb95a363144efdb21977cc7f1912a8": "psoriasis",
    "432d404973ba41318c6fe93752543d01": "active tuberculosis disease",
    "271142dba562457da03647b4042bff41": "pathogenic mycobacteria",
    "a96c132fbe5e40d5a762f6f9583a5c81": "latent tuberculosis",
    "4b0eb00ff2664722917b55ccb33b9689": "LTBI",
    "bceaab52532745f2b18e2703008352a9": "active tuberculosis infection",
    "a2d8fa1d4aec4b51af662fbe80cc7535": "latent tuberculosis infection",
    "fc2548420f034a03b63b99f76249f358": "active tuberculosis",
    "f901b6519f424119a7fa622c79803825": "eight",
    "0e43309febce41e0bc84f3276562043b": "tyrosine kinase",
    "10f594ced5e64fcfaf6ab93cda76d0f5": "hMSH2",
    "ffeaee2811f94587ba59b0c3f1305a3a": "actively transcribed strand",
    "e3dbeab284f84daeb820a11a28cd701d": "RPB2",
    "6b2c71580a6f442ab8605c69fe2e4b66": "transcribed strand",
    "e0f30444851747c08e3a6c06ba0be328": "transcribed strand",
    "8dc0bd08c09641c4a267b4b2ca0ddb25": "RBP2",
    "0ee48960a85e4cb08d71437204c23131": "transcribed strand",
    "a279fbb04c944d8dbfb90dbe26a570cd": "transcribed strand",
    "d161b97805de4abe9ce8e5aff755c987": "APRT",
    "eda2a1c711434788b5b1baf539f5db9a": "UV - damaged reporter gene",
    "a9840cebbd6f4308916ff40aa8133f59": "transcribed strand",
    "84dfe31ea9704f369ff876aaf7937ab8": "transcribed strand",
    "9ee2e86c5d1a4a1a9251990f2f2d84c6": "beta - galactosidase reporter gene",
    "efd1383cd601413086509fe1a865e7fd": "8-oxoG",
    "eac37c9c5ffd4618bcc7270e473097f6": "transcribed strand of active genes",
    "d4a589e25b7e41539ef282bbbf96e4a6": "transcribed strand",
    "d013353ea4e742219ed6b636f0489445": "transcribed strand",
    "fdcb8dcef6764b62b68b68ff7284f24c": "RPB2 gene",
    "4b717cdd7b514fb5922ab011286b4110": "transcribed strand",
    "bcb2d242686c440fb698f05cac959004": "dG - C8-AF",
    "dfc374abfd1246c8bd30686662c51d05": "transcribed strand of active genes",
    "6960bdbb74c3432a83bd3a3c0a6c30f1": "abasic site in the transcribed strand",
    "1cde295a27944b1b94e1e91a3f0c2a84": "dhfr",
    "9c43fc43f2544ef0aba121cf1f3cd2e9": "transcribed strand",
    "bdc9cd8b282d4eb29e42242885c5b466": "strand - specific - PCR ( SS - PCR",
    "684689885e4249239d6a8040baf14481": "connective tissue",
    "4dddb3b7e1e446fe922c7789a90fc99f": "skin",
    "93c9b82b1f4f4d52ac7e695d7d49694e": "connective tissue",
    "549476d728754e0e979168d1b056eae7": "connective tissue",
    "c4aa033a18f745d98c38639082418fe4": "thin , translucent skin",
    "4e62eca3bf0e4c1ebc9b576649a1ebc5": "connective tissue",
    "1a2e7aaf9e9148c98bfc8b68db1ea274": "connective tissue",
    "ddecd10050b24b4abea3af198ad1f3d2": "tendon",
    "10de1ab61b0a47219444a92bc141d960": "skin",
    "82da9c6e605c480c956b7f95c0e9d90b": "connective tissue",
    "e43d93e0fc3b425690165278b7db59e3": "connective tissue",
    "10f8119b74f94e56b81c9c59ad105093": "connective tissue",
    "43917eac9f9f4c7095a7adc22a283663": "the skin",
    "0fd48e8ecbbf4547af93df0c4d6ecfe0": "type IV",
    "09a953250a1f4db4816c782183c4fa89": "connective tissue",
    "ea17a6333c81457d803d594917b8f0b9": "heritable connective tissue disorders characterized by increased fragility of various non - ossified tissues",
    "6e14727992524632b60951a020c5b358": "connective tissue",
    "2400eadb605d444e87f69ff530a1856c": "fragile connective tissue",
    "3db08ec88fe14bf684b334546499f137": "vascular subtype",
    "90435bdf04fb46fd88c52fcb14d2c478": "connective tissues",
    "151aa629d0054dd180576c092fb49055": "soft connective tissues",
    "04374cd790ae4b8a9eae1bd08859a21e": "connective tissue",
    "922ae9318d264f8ea1e929e98b4bbe0b": "connective tissue",
    "84ecb54e06cc44c78c9482f8b29d119c": "collagenous matrix",
    "efb13b867d664aa1b52ab77cba850165": "soft connective tissues",
    "ce06b70fdbb149389828f705b0d6faaf": "rapid evolution of enhancers",
    "2127733422e64157bc1703f3baf19fbd": "evolve",
    "c5f738e45b874642afbdf22cb1b0c970": "drive gene expression during development as a result of transcription factor protein binding at the enhancer sequences",
    "444e58e7c396480e8fcad64fbbced173": "enhancers",
    "938e72116a3b4c978813f177d96b52ba": "autosomal dominant",
    "ec124190a5da4d4fa7754892711da6f6": "autosomal dominant or an autosomal recessive",
    "30297cdd9b004604bfbf3798dd6ebe86": "a rare congenital anomaly",
    "8d3460a44ce34647a536fc55cd18a4e1": "miR-7",
    "f6778f46650c44d6931d8bb4dfce8ca0": "activated K - Ras",
    "2729af5d87194532a74ffb452dcb9886": "DNA methylation",
    "1a7c755b01c04164ba29934405c67228": "mutant - enriched polymerase chain reaction",
    "7bfea0506db945dca07567f46a77be7c": "027",
    "08f0df88d96347d39f79a425ef636d4b": "027",
    "6158805862de438691239d93f7ce71aa": "C. difficile ribotype 027",
    "a94ba8afc3494df7a5e9de4ccc47fbf0": "027",
    "e08396e636f94ad19455f09fad2df0c8": "ribotype 027",
    "25f9511121624df9b2da1467fc1efe81": "027",
    "3624fe9b9dca47c98be7dc8c2d2db870": "027",
    "38addabed56946b49d470b639537d475": "027",
    "8076404cfda8488c9fbc09080b95dccf": "extension of an oligonucleotide through telomerase - mediated enzymatic addition of telomeric DNA repeats",
    "3b3c2659bbbc4cff90c610175d5dae05": "ADAR",
    "67f5860ba0e248caa2b54394c294ce80": "ADARs",
    "d56d38b84b684192b16ecad81b0152c7": "ADAR",
    "39ab6d3436864e6ea8cc1a577a441db5": "Adenosine",
    "9bb16ae9ce384988b2c0a173f93c5be4": "Rnp4F transcript , is an example . There is no evidence yet to show that Adar",
    "ed3c30f4b2954727ac67c7b6e40750c9": "P transposable elements",
    "9ec37c93f75941a1a648eced56f60b4f": "ADAR",
    "5acd66116f6c494d9f3ec6bd4ba2c4c4": "ADAR",
    "8c9513c5db4344709452efcb0a8fca01": "inosines",
    "88255af0d4234ad09cdee7305967cf18": "Polycystic kidney disease",
    "f11dbef10d7344129874377bdcfdef01": "polycystic kidney disease",
    "c5bec275c58b4f4e81b005aac5c0e82f": "Corynebacterium minutissimum",
    "f20fb69656624faba286b877bd7b0c35": "Corynebacterium minutissimum",
    "621a8b1e22974c4191648d5fc91e9ce2": "Corynebacterium minutissimum",
    "9de1c3ee5251428fb8ddac069c49e9e8": "Corynebacterium minutissimum",
    "f259dac2d37f4a20997aff4a16f394eb": "Corynebacterium minutissimum",
    "061225f92c5f46b29866ab54751d547a": "Corynebacterium minutissimum",
    "c5a3515ce38440f0bf803e4cbe2c9b10": "Corynebacterium minutissimum",
    "6216a4e8801a4b69bc9d147d4f205120": "Corynebacterium minutissimum",
    "9f45a919c4ba49198514e6173ce5710f": "Riociguat",
    "785d411170fb461891f9aaf5794d8c28": "riociguat",
    "1c213ca20e164591b8e737b5184e9108": "Riociguat",
    "80fce1b132884d6693c43fd6e45e6cf0": "Riociguat",
    "1a49f6b645ff49e59f4946d1e6242dc5": "riociguat",
    "0b96af4f05454584acfec3b094cb01bf": "structurally altered enzyme protein expressed by the mutant gene",
    "17805ad0408c48df91cdeb947ccf3371": "a recombinant version of the defective enzyme is expressed in vitro and administered by infusion",
    "81c1da5cbe684802901524bab2260719": "alpha - galactosidase A",
    "16952fa330f540e6884c87a1a0567566": "lysosomal alpha - galactosidase A",
    "cd3dcbcaf34943d0be36358f319a997a": "Human alpha - galactosidase A",
    "133771e8d5b9448681074f5d120771a8": "metalloendopeptidase",
    "0e24607baaa74369a7171110551ca197": "murine Fgfr3",
    "d053f9773d0649b8b2acea49e06af19f": "FGFR3 ) gene",
    "761f9e814759455eb96445c42ae4b986": "P250R",
    "9e843dbf324d404f9ec7fd6b491f8693": "FGFR3 ) gene",
    "159fb9e0c8bc4d909f970547f876d1d4": "calcineurin",
    "e689ed17e25f4a969ae75153c594f23b": "Calcineurin",
    "ed2c56657551418794065dae4cc3bb3c": "calcineurin",
    "8c7b90d3f4324749a409830dd407b9ea": "calcineurin",
    "0109efd350d2412484e85a1d74f44015": "calcineurin",
    "f5da104a83c341a2b668ac142d827213": "Calcineurin",
    "95cd880240a7419293999192f422b60e": "calcineurin",
    "a04105f6bf4b4673810a0bf54d8c8206": "calcineurin",
    "4739d60b47ce43b3a2834c15aa922cab": "Calcineurin",
    "e1cc331e63084604b15264d8724c20de": "calcineurin",
    "da7f2fd5258442938f8496ff49ace9a0": "2B / calcineurin",
    "302b827bb3634be7b8c958d4d56fa6da": "filter - aided sample preparation",
    "33ef66d3e9fc40e58b68c9f3044a109b": "inner mitochondrial membrane",
    "d40f8b57b37941beac2d486723c72a73": "immunoaffinity purification",
    "4a495d88d0714bcc97e38046daa518c9": "CADD or a bespoke machine learning method",
    "ccaf40e8947045dbb86dafd325b2f626": "LYST",
    "a03dcd828ad547288622933b68946271": "lysosomal trafficking regulator ( LYST ) gene",
    "25cc4073015c444db3084d4edbb2c04f": "lysosomal trafficking regulator ( LYST ) gene",
    "c24c1289233c489691969ee391245427": "LYST gene",
    "9d193028d5e04fa68360de77146992cd": "LYST",
    "49a8636768594ec69306fe7ad061cffc": "LYST",
    "6de488eb1d614d6d9605a4bf3e86a220": "Lyst",
    "f1f7239d2a0c4cb885c35010f04d0b4a": "lysosomal trafficking regulator",
    "b281754e18ae429e9ea7345319018381": "Intravenous immunoglobulin",
    "aa3bd2754c49481280548e95e33f1438": "phospholipase A2",
    "5b8df96552584828a665c27a635ad167": "sPLA2",
    "206aa6a2af2042ff92e09f48ea2bde5f": "human secretory phospholipase groups IIa , V and X",
    "9f57803776af4b0bbe0deae68fbd40b0": "plasma sPLA2-IIA",
    "1aedf35d15b449439a4efb13c4c5ebd0": "sPLA2",
    "9b9bcd725a354906b933c55de76f23a8": "sPLA2",
    "5326d703c9324e3ea9439b9de254c05a": "sPLA2",
    "d7642cf38cf1490688ccfa02b942b4ab": "ibrutinib",
    "cafa66fb437540ef9aa450b70b36bc58": "ibrutinib",
    "1deabfc2b8134cc6addbbe34af4c2d6b": "Ibrutinib",
    "bd86734b94164817a2682dd869cc2412": "ibrutinib",
    "a223c16cf85f41ee87a3f1714a34aad3": "Btk",
    "e34cd287534b4fd788442be110013bba": "Ibrutinib",
    "6696f9c425644649871fb87ff9a6ff0d": "ibrutinib",
    "692ffa1dbcd344f7b86b7f0d61e5403f": "ibrutinib",
    "f0635aa1d547406894740b04dba27d43": "Ibrutinib",
    "f2a99dbd8b2344b8b93f9e08e0029f24": "Ibrutinib",
    "6999c77ec9e74a558797ede82bccb01b": "ibrutinib",
    "1eb2d0fe88414c37812859c1e4d6e1b5": "Ibrutinib , AVL-263",
    "020cf00b943b468f9e50ce04bee47b9f": "motor neuron disease",
    "56561ee2c5e6437da905d1d0cb1db046": "Amyotrophic lateral sclerosis",
    "de7ad57d11e84ddf995786a4c2ecdfe5": "amyotrophic lateral sclerosis",
    "c2ede5c0cfed444bbea4d8c26beb9b7e": "ubiquilin-2",
    "512ddca4bf4d4b0b858b5f2fc87b8f28": "Myc",
    "483a3885738d4b65a527e3fd3445ef78": "2 - 4 %",
    "d2affbf1297d4be7a210c9cbf1cccbba": "apoE4",
    "84150498c316405889993b5f785ce213": "ApoE4",
    "2a8c06afe76f42f9ab06708b3adc27fc": "apoE3",
    "2594b3b5c34d4b7f830baf5eb3094b4c": "ApoE2 , ApoE3 and ApoE4 ) that differ by 1 or 2 amino acids . Inheritance of the ApoE \u03b54",
    "19f812e350824082b6b21522a0ba9fa9": "ApoE4",
    "27c2cbb7582d45599f9b7c6674f08fc8": "APOE - epsilon4",
    "0d068226dea64534a6062b1fe2b2d4a6": "HilbertVis",
    "fcb4893a6cb14ad6b24d3eecd91305b9": "TP53 tumour suppressor",
    "02a0b88b776d4b2d90874b4cebd2bc40": "NF1",
    "15f2966fce5a4fd499e583236823391a": "neurofibromin",
    "5976ad62650747a3bc3be03c0e430c7d": "NF1",
    "66fb49bd52204318bfa262bfd21dadd7": "NF1 allele",
    "5f0e0e9c78bd4056be4db4e527d130c7": "p21 but not of the mutated . An NF1",
    "0fbe509cc92143e19f8c06a29e4137e7": "NF1",
    "b4e786bd8b8a4087859d3959d3641b2a": "allele",
    "0d78800e67c54fad88dcb0110c4ca8f4": "NF1",
    "354f714bfea84f6b8e02e7acba3f7d67": "messenger ribonucleic acid",
    "50efbe779a774f9abfa654638c3497ac": "NF1",
    "0c9f8e9fe860401ea6dcee5e90c43f6c": "NF1",
    "6246c07c53fc4659a83f4955f195a4be": "NF1 ) gene",
    "fb9d60b81eed4b7e93174fdf341800eb": "NF1 gene",
    "85c02eb57c7c40d099713e942323c658": "NF7",
    "d0289ed00e594970840413f51ee34e30": "bone morphogenic protein receptor 2 ( BMPR2 ) gene",
    "1edbc77172904d679ba101a437cd5cbc": "Lysine 1423",
    "c9db9e67e67b4c408b9e053169e05a70": "NF1",
    "40227f76b00344a78411177630545e7b": "NF1",
    "8264477aefe0438e81189bea1f1be19d": "NF1DeltaE7",
    "c0d1452ed8b34c4d932f62aae61d37a4": "NF1",
    "6f4df195db2e4569b74922aec8abb058": "Arg1276",
    "630e79bc6d3e43a69d8e28cfdd721151": "PTCH",
    "beeb58f583fa4c9192e2fdb72f727d1a": "NF1 gene",
    "1c8a233817e24aaf970974c3d66dfce4": "neurofibromin",
    "4512014da03b487ba5925f69cc357394": "Rapamycin",
    "2b5a9a60a149451fa5beab92cdc9a704": "rapamycin",
    "344979f88cea475c9aa74a98325a3ad1": "mTOR - Rictor",
    "f64f5b4347d34aeba65aabe6813b3e13": "rapamycin",
    "51c0f6328c564f34adfee63c41eda084": "inhibitors of mammalian target of rapamycin",
    "0720cc54f299433bb58ec7af596a77c9": "rapamycin",
    "ed55487bc74e470cb49c16f051371c9e": "rapamycin",
    "5fa3ac51559646bc97a2d2bda7967890": "rapamycin",
    "1d067f852f5b46409f02c83de355022e": "zinc finger E - box protein 2 ( ZEB2 ) gene",
    "ace3060b5e2147889d7d4709d6cd1e57": "zinc finger homeo box 1B",
    "65d32f6d9c06430c970f8b3020a54497": "ZEB2",
    "c280b30564a84cffb0c76349584f7d2f": "ZFHX1B",
    "49821b4f42eb402d87d1e96b5eaef2d8": "ZFHX1B",
    "6aab95b5bc40449b812caabddc308265": "ZEB2",
    "111434d707cf40b1b4d6056ddfc2f280": "ZEB2",
    "fec222083ea440d4a439d10720ceb994": "Zinc Finger Homeobox 1 B gene",
    "e29d0b192b44413e95a08a2afa14fcbc": "zfhz1b",
    "66de6d84167b4ec996cf97c56aab9b0c": "ZEB2",
    "319083e67cd448328850b8010c134c4d": "ZEB2",
    "d84bc6e39f2f44b6973107b386e250ba": "ZEB2",
    "8870a7ba64174735af9856e72fd82aaa": "Smad - interacting protein 1",
    "9095328339f447188880bc5412e035d4": "ZFHX1B",
    "c3272be6bdea40c9ac22dfe5337dc311": "zinc finger E - box - binding homeobox 2 ( ZEB2 ) gene",
    "ba508f5b8dfb4fbc83ecf9831706b686": "ZFHX1B",
    "ec16938dc3e040ca96362ca7d7677913": "ZFHX1B",
    "ecab61b49d944c2daff330eafcf4f174": "Facioscapulohumeral muscular dystrophy",
    "fb6050311b794585986ab4a8b17b564e": "FSHD",
    "7e10e131bea248ff97cf2ce156eb3fbb": "Facioscapulohumeral dystrophy",
    "874766ca4acd487abe5fd450dda756cd": "FSHD",
    "942b79bc7d384edd901fe2769f46512d": "facioscapulohumeral muscular dystrophy",
    "5d0d556d41284947986e2a22525e867b": "Facioscapulohumeral muscular dystrophy",
    "1e975a42f37e4673a2b441a56ec1c446": "Facioscapulohumeral dystrophy",
    "a6bcac6859cd40d8bd74d2ec396850ff": "Facioscapulohumeral muscular dystrophy",
    "69c2179d41c04582949a39853d960dbb": "FSHD",
    "7d7dfb5ece1846bc8fab1c8af7bcce92": "Facioscapulohumeral muscular dystrophy",
    "e6310084df7a436e828bdf5b509a3937": "FSHD",
    "e2c7168e86b7402987c3b9727658207d": "Repeat contractions",
    "7247ffe169f140339020744b6f54923c": "facioscapulohumeral dystrophy",
    "6a92b3312fe9468e9d709a8e59c9fadc": "facioscapulohumeral muscular dystrophy",
    "c09b13353ce8449cae19747d33b78dc2": "Facioscapulohumeral muscular dystrophy",
    "3ab6c2600b684e3c8863255de919f559": "Facioscapulohumeral Disease",
    "4fc29c2642a542c698f2e6a566dc9c37": "FSHD",
    "c3596cdec1b2483b889a950b0ae18039": "potential roles in fine - tuning the RNA life cycle",
    "e2dccc6fa3a84b67a72cd87b03a0db2e": "stability",
    "91ba5f0e9cdb420b8e49daf63935d388": "\u03b2 - galactosidase and \u03b2 - hexosaminidase",
    "c44c66126f324ce3acbc22cbc8a73352": "IL-1\u03b2",
    "f129d78a420746cd9b0364aa8ac1fa28": "XOMA 052",
    "8ed1ba42499c4aceadfd18b13356a2ba": "IL-1\u03b2",
    "e156bae24ed442c581112e4b34e212a5": "IL-1\u03b2",
    "ca7d8d2c7da042fab1a0748d8ae115e1": "C - peptide",
    "5389373ddbe048119c1dbeb0494dd528": "IL-1\u03b2",
    "2f0cee196ddb4065924495ca24e444df": "Canakinumab",
    "dc412b85fe524e26a165bb4c60c19e0f": "pulmonary arterial hypertension",
    "69acbdb73b2c414cb48a711bb6da31f1": "pulmonary arterial hypertension",
    "8ed62063f0ec40858e6e327239600c08": "pulmonary arterial hypertension",
    "d69c9463ec08444a919447d7f33855f7": "disease progression",
    "990c3fbed6b34ba08dd9a7685e257613": "pulmonary arterial hypertension",
    "510b9aa3109f4e7c94f4cee443af85d9": "CAGEr",
    "9bf503906c3b425bb54cf156d27e9101": "Rac1",
    "76df6ea078eb43ef838474f8a30b5d15": "ataxin-3",
    "179e834f3f064c7188755ef9596db9d9": "ataxin-3",
    "5196d6a345bb4a5db1019bc0c286be72": "ataxin-3",
    "cdd24e60bb144851a40edfa54e99d30e": "polyglutamine expansion",
    "353a222964794361bdaaf8ea481c12ee": "ataxin-3",
    "e0187e9fdece45e5bba46192786ac6b4": "mutant ataxin-3",
    "789a207c9dc24db295601719ba0be075": "ataxin-3",
    "5e25c3d45f5646e79edcd84d6308a178": "Ataxin-3",
    "d3819cb8ec4f4b7ca419852b254520d5": "ataxin-3",
    "b4fcd51ad7b44e5b973a0b67bc523ce8": "a calpain fragment",
    "ff352f0d6455402e93166f8e35e032b3": "AT3",
    "3b79b6f68f774f36a9a24a3a0960be22": "ataxin-3",
    "df45d243d5b846c9b8dd26f62bbe479e": "formin family",
    "acb923e812724d94bc4863897a19ef39": "murine selenoprotein - P",
    "109aecf700c048eb8d16d5d20b654c22": "Selenoprotein P",
    "c67a56187ba94d478fbc8c8608cabb52": "Human selenoprotein P",
    "b54a930870644fa1b3afc3f2c6bb1029": "selenoprotein P",
    "bc72c59b993848e78839cf94591aaa7c": "LDL",
    "5eea1742ec204acbbbefefd542130ee9": "Selenoprotein P",
    "47da715dad124f3690dc1764042458cc": "selenoprotein P genes",
    "ac71a6d1dc574af19a94520c1b63208d": "cDNA",
    "7a2f5d7d054743f394fabcf4272d4fb5": "selenoprotein P",
    "69bb73c08e1848e080576cacd9b2c307": "TOB1",
    "5ad5edb13de04cb2b3191b68d0eab76d": "FOXO3a",
    "ea59c7ee76424a47bdecc74c9987666f": "aging studies",
    "28273676388a4bd8b10c28cc78703649": "aging research community",
    "4f5281fae53d4f948abc936704d3dab3": "Syk",
    "a684e2797a984c48b274c3513981d491": "spleen tyrosine kinase",
    "9e08a0761bde49399ae1e7eae4dfde2c": "Syk",
    "16300354ea174c638aed9b7a90b41019": "Syk",
    "7c88f7862dc74ae8bded750a958b2e65": "spleen tyrosine kinase",
    "7deff88ee57a42abac5151b2659908da": "spleen tyrosine kinase",
    "da2a8dc6772a49fb956f810030d12b53": "spleen tyrosine kinase",
    "f793e627a2a246e4bdb80b8e39f246c4": "Syk",
    "6cdfaee03ce4412b9875775aca7ac48e": "spleen tyrosine kinase",
    "7a4fa67d3e7042d388d3a34034a61556": "R-406",
    "89a7ef2839a844569cd9d4d936eba6c3": "SYK",
    "fc8abf2bd2b748b1b2b83f689571c1fa": "Syk",
    "6058f2f8356844f09683a30ad50f344f": "Syk",
    "15acdfafb8db4713a4ed63acfd61cd30": "signaling pathways downstream of the BCR",
    "817590b6c9a647a5aef10b85199aef9b": "spleen tyrosine kinase",
    "09ebf96c823548e9a0908cc35606cc13": "Syk",
    "5742d0bc42aa44c8a4614ab95fa1c3ff": "R788",
    "ea2c422448e642a6989d21e8c090f77a": "spleen tyrosine kinase ( Syk ) inhibitor R406",
    "782a069dddc14cda828565a5f8c628ff": "Syk kinase",
    "68d14ce5231c4bba93f1b52c90dd2f8c": "SYK",
    "5b4281bf26774411a2c18e34edadb7e3": "spleen tyrosine kinase inhibitor",
    "c39a985f3db547f193720f8ea9d1d8ff": "R788",
    "fab303bb445f49959138cf04ba36638a": "TKIs",
    "02fbe83948a24a63a98bde04a8c8943e": "SYK activity",
    "cdffae7e17c6461b9d318dade835ff28": "R406",
    "19279b71c3f24df98e4583f3b5b1ad1e": "ubiquitin - proteasome pathway",
    "19e748f08da643a884cd0cba3332ced8": "proteasome",
    "24304bc9cd534c35b4dd425e73e67aa7": "ubiquitin - proteasome pathway",
    "0ed20ead469f4406ac6977afdfa3ba6e": "ubiquitin - proteasome pathway",
    "db311c7e2115419da83e01e6c5610862": "multiple myeloma",
    "457215d830bf41e89e644ec8a579e6a3": "Diamond - Blackfan anemia",
    "796122644c79446f872e37f300157090": "Diamond Blackfan anemia",
    "575a6d0ae33a41199e0f015ee20f982f": "hypospadias",
    "0f4f89a6d7184d93bab72240637a0ccf": "Diamond - Blackfan anemia",
    "64a4ffe678aa497da235a1cde7d5712e": "anemia",
    "2ff9e79323fb48ad9fe911c391aecaa8": "DBA",
    "2f5baf79244c4758a2924c9c539783e3": "Diamond - Blackfan anemia",
    "f987a6c739454ffa9a27e24c4e5235c2": "Diamond - Blackfan anemia",
    "85af34b4c81f4eee8ca3336339fad285": "Diamond - Blackfan anemia",
    "35f2d4aeaa304a9d9c6fb6f5340d5589": "Diamond - Blackfan Anemia",
    "141cca4558cd4f99b00b0fe5066754ca": "Diamond - Blackfan anemia",
    "18ad572dfb52412caadfcb13edb5accd": "DBA1",
    "0bede4582a9e40d4bb498c8ee7d6c64e": "Diamond - Blackfan anemia",
    "f06fc76bb7624c4ba8baf1c01fb0c0a8": "DBA",
    "7b98e597897f4b24bd7030143bae73d8": "Diamond - Blackfan anemia",
    "3485a7dc574240ef8e15dadfb984bc14": "bone marrow failure syndrome Diamond Blackfan Anemia",
    "f6d7e1841db1466093bc4a2667512ecc": "Patisiran",
    "1d9e22d6ebaa441090217077e2711e57": "phagocyte",
    "adf08b78ff7f4b26bfe31413163ae9d5": "NADPH oxidase Organizer 1",
    "305e48f06a854133811be7ee3e983da5": "p47phox and p67phox",
    "6779bef390824d269a423840772240f6": "inflammation of the colon",
    "9a318d833d4e4621b879888b71809161": "Nox1",
    "976535f8681e45c9881400b1e940a908": "NOX1",
    "57eb41d2c868493082e639c7f17fc839": "Nox3",
    "e662d0daac3047e6bbb879f08d0a56eb": "Nox3",
    "fdc8771a13204b6eb28d48a0e3f1d6c5": "NoxO1 and NoxA1",
    "ce8e78ef06ed459386b6f776879b5c3c": "p22",
    "3d080e8520c34ceca932d863f5e88a76": "p47",
    "809980294d6346f88b44bf8f45d50ed7": "Tks5",
    "1d136608f31e4ac89782b0aa4082ddf6": "NoxA1",
    "a4ff84e6a2b74095928e6c42a934aca5": "Nox1 , gp91(phox)/Nox2 , and Nox3",
    "7b72b7fbe25641d2afc299fbcc7284d8": "p22",
    "9017897d71c2434d90f474f17544eebd": "Nox",
    "33aa8ce035c44ae2b854b9bd20914504": "dihydrofolate reductase ( DHFR",
    "3e6978c75bef49edbd8b728bbe7b06de": "Nox2",
    "c9411266b7014dedb3a042e1c5632fa7": "Nox4",
    "d6fb14e3be8245baaf66693d4b546e8f": "nearly 100 %",
    "cecd920cbb724d98aaf99c70c2dcc371": "iron deficiency",
    "bf8c21d529d04c91a88adc9ab2db2f61": "Iron deficiency",
    "f17066e29bca4700bcdd4b135925f533": "iron deficiency",
    "9a096b481413444ea01bcdaa55383924": "iron deficiency",
    "d4042c8ae89c41c5b5b34e283593ecf2": "iron deficiency",
    "174f261677d84e0880d30296aca0dc8a": "iron and decreased inhibition function of spinal cord",
    "012f50f15b46427a95f71bd22cb9066f": "iron deficiency",
    "b473484f66344d0eab8d7d0180fd88e4": "Iron deficiency",
    "a60d3d614fee41baa0ba11c2f3e0061f": "Iron deficiency",
    "aea77da44e294600b63d4260d7490d59": "iron deficiency",
    "b2a12b8918344a65a2cc5f9b028e8d2b": "dopamine transporter",
    "f86ef5e1ac664cb0a799f69a2e54f94d": "iron deficiency",
    "cabbfba13115484cb3e878c1ef67ab6b": "iron deficiency",
    "cf13cc1b9e0a4705a20d0630e0acbe2a": "iron deficiency",
    "2d73138d00bc4dfc99e39ba6f78babb8": "brain iron deficiency",
    "2db766b5f95d4cc9915d3477fcc2df52": "iron deficiency",
    "e633c81c3daa42ecbd9ffd1b9f3106ab": "RLS",
    "e001a3c4b9fb42529a630cc6884b137b": "brain iron deficiency",
    "f7f92b936c074e0eb3a943162c19c19b": "L - ferritin deficiency",
    "98b6b16cb95a49bd915989305b3d7d4c": "iron deficiency",
    "c11e38b5379143f9895440d3ed5f0ff2": "iron deficiency",
    "3216ab3e241a45eea283765e3bee89ef": "Iron deficiency",
    "bbcb4c12247c4dfe95445768887501e4": "pramipexole",
    "a118373d91094ae6aca3047edf9b0bac": "IV iron",
    "240a062b131041ab863a237c0c0a8a73": "iron deficiency",
    "9027c3fd24a14863929469111bec18ae": "cysteine",
    "04da2c70e07e4c2581afe158af0e1759": "cysteine",
    "a13b2f0d01ac4624a36ad19165836bef": "cysteine",
    "3aa0a515baa742df87b15ccd76e1ea2d": "cysteine",
    "18b6217da1e544f0816a04e6db73ff7d": "cysteine",
    "dabfffc898254535a9a607a6650d2562": "cysteine",
    "bcde6357432f432684078b4f2374b9d8": "R75P",
    "5d67f3f3e8fc4a01a62f519db556744e": "cysteine",
    "ea472668bef643f08d9793d914e6370d": "cysteine",
    "d2fdd08c60094d70a63f61dde1ded606": "phase 2 - 3",
    "a9464ddc76874f33bc3080db5c5c07b9": "contraction - independent FSHD2 are unclear",
    "9c3b896a35634a75b5d535c858119572": "dominant",
    "4aa2254c611946849f987fbc7af289e2": "dominant",
    "5ae5529a5ae241daa090d3d9f369eb09": "autosomal dominant",
    "a40ec3c2b8dd4fa4a955eb489be36aa0": "weakness of the face , upper arm , shoulder , and lower limb musculature",
    "59d3efb511ad4c1d90d9b4c980a562c2": "autosomal - dominant muscular disorder",
    "ff8ede38609d4622af0f985023a70e89": "autosomal - dominant",
    "6c9b255f11a04caa992ae6ef8de912b0": "autosomal dominant",
    "a5ad0e37d1f0478a95e9c90fe01032e3": "autosomal dominant",
    "9366db61286b41f79e9e069494d2c271": "autosomal dominant",
    "0219464e052f47129d0aa71da3738b73": "autosomal dominant",
    "6bf60ce1cd73408f93464f39ccdb6be4": "a quite poorly understood and inadequately defined phenotype of methicillin resistance",
    "6b5bba7ac78e49bf91eca71131576311": "a failure of cloxacillin for a patient with endocarditis",
    "a859d7dd48d14f7ba82f37892f524538": "Borderline oxacillin - resistant Staphylococcus aureus",
    "550dd36b5da9418ba956fba3c25e7423": "borderline resistance",
    "4da97c18b61b4722ba0a7e536831f947": "unknown",
    "3d2f68914f0e4658990df1920e00cd94": "MRSA",
    "d3cb2ae20ed644fa9da62fd47344b395": "borderline oxacillin resistant",
    "fd51aa90ceb147e78cd27c4328ac7962": "controls for non - disease - related variance",
    "49b937d0ed614da79079221407d48ab8": "schwannoma",
    "95bb8596ef944c13a5524065ba54cbb9": "vestibular schwannoma",
    "44cd890f1a1b4d6a9b055e363d1c3221": "Hearing",
    "daa709616eec470dae4a7428b85cf00d": "FN",
    "212829ec9421495797a732770b08731b": "facial nerve neuropathy",
    "82b7ad0ac3da45f8850154988038abc3": "vestibular schwannoma",
    "9a266ab5385a487db6485e67274c6e1d": "microsurgical vestibular schwannoma",
    "1a4946e6636c4ab3a37f421bb4397409": "treatment of atrial fibrillation and flutter",
    "7d3f2b1fca4442a8ae60dafaeaa4cb04": "deltaF508",
    "721f570c564a469791dc784b8d46492b": "p . F508del ( DeltaF508 ) ( 18.1 % ) , c.2183_2184delAAinsG",
    "64d835315a7e48858f130cb33645cd8c": "DeltaF508",
    "b59f8200d7c241df95bf00fcbea3ba21": "memory loss / lack of concentration",
    "01296d63b9d147bc84e380acbd71b4cb": "spinal muscular atrophy",
    "929fe34ca98f493f90876a2789451097": "SMA",
    "0ddc50b6e2eb4c54b88303df7172ac37": "spinal muscular atrophy",
    "8879689c14314feb9629e3d724500547": "Spt - Ada - Gcn5-acetyltransferase",
    "513f317b2bbb49a488431854ec8b1291": "TBP and TBP - associated factors",
    "c407bea87e58496cb312d3fd2e5eedc2": "deubiquitination module",
    "60b7c837674146058fe26d85952d6ef1": "LHCII",
    "e65867b72b4e4b6cab1e8ae033a60312": "chlorophyll a / b - protein",
    "25f0f26d8d674227bd9950f0a956f541": "LHCII",
    "6b0148faa55441ee8fdde13fe55edb87": "LHCII",
    "d30650e611f64f46abbf5b525ce53a92": "Light - harvesting pigment - protein complex of Photosystem II",
    "d8b6714eca6845d68ff4a83b405e4a77": "early",
    "55f7e26b1a6a41c08f110ecb1c372358": "late",
    "f86ba8d933b746bc9dcc170bdad24a09": "early time",
    "4d4e76e2c6944123bd9d9709e0e9d250": "psygenet2r",
    "e7bc7aac09da4b57a6c64fa1b67bf938": "lysyl oxidase - like 2 ( LOXL2 ) enzyme",
    "09d197c3c5924d1ca53e19a939eede2e": "treatment of scar formation",
    "b15e8d06f5fd489fabcc01ff6245e692": "a monoclonal antibody against LOXL2",
    "9e0895388cc345f698305bfff766a304": "Bacteroidetes and Firmicutes",
    "23231ba1735c46b7b4dbacd35b95a111": "rfx6",
    "2e07fab624c345f486c1445ba1811034": "RFX6",
    "42652e9339554e27af6c273cfd698386": "Taz",
    "fd56ae32cdb74808971cdd1f6e9b58ae": "streptococcal pharyngitis",
    "6952c83e31114a20b979dc5962329901": "Group C streptococcus",
    "345cc6f39eb0472ebb37229e6f4e34b1": "petechiae",
    "e8f16ae3e5874a4181985bd826ce59f8": "streptococcal pharyngitis",
    "5b937d99df5342ca8ffb9a12ec8714ce": "inhibited",
    "61ec5684d44c4296809c466509051021": "inhibits TCR - mediated signal transduction , cellular proliferation , cytokine production , and in vivo T - cell responses",
    "8a95f412e40d4b0ba12e01f67102652b": "one X chromosome",
    "4d9adbc83c164890a231325d350c9a93": "X chromosome",
    "d691510d9c1e401ebf6364b876537b48": "chromosome 14",
    "80b1b799ab8b4a54ad19e73ff5640506": "X chromosome",
    "1fea59437aaa4c8d9584b01338bcf0c7": "X chromosome",
    "00f4c5c0e5df41acb2f90c62057cceb8": "X chromosome",
    "1a3826a79f32433bb7acdf6f53049b19": "X chromosome",
    "f936edc724e441e3aee4d610eb000a14": "45,X",
    "0c3d11aaf8cc41e7937743b05820136c": "X chromosome",
    "6874df2a5c5d43888cd33a65d4def0f4": "22q11.2",
    "f60eb4dfa5774b8c8a56567d0989deff": "45,XO ) . The generally accepted hypothesis to explain this discrepancy is that the number of genes on the mouse X chromosome",
    "2a29c11eb40348279c1e857ce85d292a": "X - chromosome",
    "24a7496511044cb081a2b7f0953bc895": "X - chromosome",
    "12fa90a3c056479a92f47b23fd5275bf": "X - chromosome",
    "f06f14b35c864f9093f9fae1b78fcd15": "X chromosome",
    "9aae75f96acc4b5ba4f5bc32a39f1e8f": "X chromosome",
    "fb9765068c0047e8994ba18eabf79e88": "all or part of one X chromosome",
    "7e00d62adabb4717889af97b4ed46c4c": "X chromosome",
    "a6c94ff890694dde8583eedd2e670526": "X chromosome",
    "b2838cb187da4004873628ecd5e3851c": "nucleus",
    "9369385dfdc54cd5b5310b9caa60fb49": "PI3K - \u03b4",
    "eb43bbf0c4bb484dba710614100c1204": "Cseq - Simulator",
    "565e79886a2d468ab49544a0c8e4d2c9": "malaria",
    "34237e2593fe47159c2577f4c10f4577": "plasmodium infection",
    "51baa45baf634976aba834f1b1354eb0": "malaria",
    "bab439e02a014e6f9961ed16f6252e78": "Plasmodium falciparum",
    "7d74ba9e281e40f4942cf692644eec7b": "Malaria",
    "e20b24502922481885eab94b612f374d": "Malaria",
    "1363ed9604ca4b6e86e3a335d50b1bb3": "malaria",
    "83bbfe9e1ba04ab5b0d56e7dbde01a22": "malaria",
    "bff1390d69824f58b4c462e5805f90f1": "malaria",
    "fe31178b0e794792bab8b7ad3722944f": "malaria",
    "08c2300228d848599dbb36a771fdc904": "malaria",
    "b3cdf347d3884750ab5f93ca7c8f1257": "hepatitis B",
    "0bd08263daf14f48abf0c2d991631289": "malaria",
    "042108de04cf40ea8e1cd8cb48ae295a": "malaria",
    "94fef0193ac04cd1bd0618898b7f9efd": "severe malaria",
    "3926de0ae12f43be8eb6f2e7dbc0cee7": "Plasmodium falciparum infection",
    "e902e6f0d961453ba6bc3e8ea9ab9588": "malaria",
    "a83fcafc8fb6472ba0ed2aea6e7a78a3": "malaria",
    "e339e78113964de2b3b0f21b5a8d959d": "clinical malaria",
    "60face353b89434397ee1fbd3aa44915": "chemically synthesized vectors",
    "0133a9c3b1f74db79d96f61d59105870": "viroids",
    "e33fefebc3a946c4b17c7aaf7f33de2e": "viroids",
    "bb93a89c6e904635a4afe3015d50c0e3": "viroid",
    "8eceba755842479382ec48217193b107": "Viroids",
    "2f0016f1f1004c60afce22d6816d93e1": "viroids",
    "2617acecfbd24533a69a8513130d6dde": "Viroids , satellite RNAs , satellites viruses and the human hepatitis delta virus",
    "f248d3aef85c4155a94ef1ebba8c6769": "viroids",
    "a1eb48cd8fd248b298836e6dfdebb1a5": "viroids",
    "023fcaa40e9a45319ee26a33d98fb40f": "Viroids",
    "4bcc2386dcef433497f13c0ffbc668e1": "viroids",
    "023fcc86e5c846d2b6220e8e9e90de4c": "autosomal dominant or recessive",
    "67b5647fc6814b5d880a3bc12a5c419c": "autosomal recessive",
    "8962f8a532fe4886b70e6d2f835f4445": "recessive",
    "1bcd341d9896445e8554027ad01ed066": "alpha - proteobacterium",
    "80d65d38d32c49f49b86b800be1f276d": "on the luminal side of the endoplasmic reticulum",
    "5a537555a5e843839c53a7739cd95f64": "lower",
    "34757c8e5ca444a192856060543f7791": "autosomal dominant",
    "8f255d79fc124b75bbeb22b7b675d5cd": "autosomal dominant inheritance",
    "83d7f282309948759aa19ff5ddcdd45c": "autosomal dominant",
    "f3e0556321574bc9984f02992df32320": "autosomal dominant",
    "857f5bd2ba3140ffa45bbf468805dfa3": "autosomal dominant pattern",
    "c56e3d34c08a4d009fb83d8ed37c636a": "autosomal dominant",
    "16cda57d6f444810a77096b293729095": "prolonged QT interval",
    "26694e93ebbc4962895a9d5377a2e4e8": "autosomal dominant pattern",
    "c68098a2b69d435d846e9305f82a5432": "autosomal dominant",
    "e5d58ee5c70045e09f9863cc375814b3": "prolonged QT interval , autosomal - dominant inheritance , and no deafness",
    "d838cda896684309ac3a07c8d28d403e": "autosomal dominant",
    "3c809ea1a7604eca9f5319c8cf28554b": "autosomal - dominant",
    "9ed4f4385bc94c1f8e4317bb859818ae": "RADAR",
    "73a1af5a2b084b75a3a2d56d9cdceaf4": "PTSD",
    "4426d2042a6d4887bdddfa6bb9150c20": "PTSD",
    "dbf89c9e9b394c7eae08a4dc8b5b7ce5": "depressive",
    "0b4eb5fc8d864052918d6cffa3730c7d": "Positive and Negative Syndrome",
    "c35f27d4167846e1adc3aadd2981e4dc": "PTSD",
    "b086ca841a4040e58142b56004268573": "post - traumatic stress disorder",
    "f39ba0ef13d74fbbbee6b6a7495a7da1": "posttraumatic stress disorder",
    "b5c03080f08845128cbb48af0b93fc6d": "tiagabine",
    "154d75312f834698b4172f50c831682d": "chronic posttraumatic stress disorder",
    "c59a1bea5cff48498990324b541702a8": "posttraumatic stress disorder",
    "9dafa681f75c4bb190fa51f4757a6056": "quetiapine",
    "cb4d005ff43d41c896f0469ab1363b38": "posttraumatic stress disorder",
    "5267f8e8067c463f853c19a12d7ed6a8": "PTSD",
    "2948595cc8ae43138ef1c66a44e17706": "PTSD",
    "fda25d478d054f8bb5e7cf002113e5e8": "PTSD",
    "3a4f863ee8e149ab960b2f0eccb04cdd": "comorbid depression",
    "b6a2b5c8312645a99ca848d823503319": "post - traumatic stress disorder",
    "462db152238a4653847a20f341201b84": "bipolar disorder II",
    "30101ccbda904d208ed2525e9f6e992c": "Axis I",
    "ec0f16c438fd46859bb3a5d270a6176f": "APOE \u03b54 allele",
    "8358e9aead9e4d0e8e8aa54a33b9eff9": "fluoxetine",
    "7b813fb8fbe444c2b8ed096bcfc51ca6": "posttraumatic stress disorder",
    "bba18f5535f945b98b8a82421bcbe956": "posttraumatic stress disorder",
    "cc8a41f6a6f0463db5968ac4b582400e": "DSM - IV symptom of PTSD",
    "a197452996814e96bc9331b41b870709": "anxiety",
    "76adb600c4da481db13a307c2a13062f": "depression , anxiety , and post - traumatic stress disorder",
    "2834078a6a4f4895bc36ef416995c4c9": "posttraumatic stress disorder",
    "de9aff425efc4c5493a66c2ba35ef6cf": "hyperarousal",
    "04c9df99ae544e2a96f40f77fd2378b2": "PP1",
    "80319100e57e4e6bae3dd5bfdc5b1543": "Epstein - Barr virus",
    "c5f3d85f9a094b98b72b423fbde816d2": "Epstein - Barr virus",
    "fba1c150697a4864bbf8aedacd2d8a94": "Epstein - Barr virus",
    "f210d60705384548a979b62bca881946": "Epstein - Barr virus",
    "57dcf6f202754ad999100460e1b5d6c0": "Epstein - Barr virus",
    "27f01386fc37446ab4eaa091c48db4f9": "Epstein - Barr virus",
    "0460fc84d839453e88d73ec2691da940": "Epstein - Barr virus",
    "2fa6c155febe4bc2bb8a93675adab78c": "Epstein - Barr virus",
    "ce748f9834504d5097c7be8b5b4ac49e": "Epstein - Barr Virus",
    "0e6c87f5f0c94291853b04cbabd336bd": "Epstein - Barr virus",
    "647cf5ef073243d2bf27e3c5ec738617": "Epstein - Barr virus",
    "a338247c1f654179887259220bfbd8d6": "SLC49",
    "22b639b52f25417c920ceec18fc765f2": "a small regulatory peptide , is the endogenous ligand",
    "fd3253087bbd4003b295d765450a9097": "SWR1",
    "76475db3f85f4bccba0b5febb2054087": "the fourteen - subunit SWR1 complex",
    "4ef05543761e4948b74e9fa078a5e4bc": "sister chromatid cohesion",
    "d2627627aba84f99995af53314a00a58": "SWR1 complex",
    "068cbc54100446149c56fc5412d2fb84": "SWR1 complex",
    "62476e02ad284ed2b1d1125d42c416a2": "multiprotein SWR1 complex",
    "c3f9a61ef7aa49b99bb12823db16f5fc": "SWR1",
    "8ab88165ae80445089f0dcaa4d7d2e0e": "The chromatin remodeler SWR1",
    "aca0c2813cab4d7ca0129b61b2f3dc20": "JmjC domain protein Msc1",
    "9473f38b4dee41f9afdbbe99bea8b018": "Z - H2B",
    "a537bf47b5b549fba4cd70b3f5e9286d": "SWR1 complex",
    "464136c1262c4537a73e251dcc6d6f54": "NuA4",
    "30f3fe33aa974d54aa12ad555cb22644": "histone H2A",
    "40d8ce56de49432180bd5735b35937f1": "SWR1 complex",
    "77c8c610c2b44cfdadd28ce51c2e8c6b": "cytokines",
    "cc706a937ac44341a23ae0cae23e2bdd": "systemic inflammatory response syndrome",
    "930ebd41e49942059fff966207ce5c03": "COPD",
    "071541cdeb9e4d6c9a4b372f6a11c778": "community - acquired pneumonia",
    "91d802a8576d4cdd95d43becdb1ecd56": "lower respiratory tract infections",
    "2b4d642eb6aa447ea6ee20683b83444a": "tuberculosis",
    "7c707712084d4ceda79cb8580017408e": "confusion , urea , respiration , blood pressure",
    "4a5e280ba4534d708cd9a706f914288a": "MR - pro - ADM",
    "b5dbf261c2ac47798a218fa9f7495791": "Amanita phalloides",
    "f4212bc102cf47dea8b1a2b10b5fe090": "E. coli",
    "0396509bd1664b019a93887131c5917a": "bricks and mortar",
    "91b011596fe84b0abcbf4608f94d3748": "cell extensions",
    "0b44e46a198e44a3a793781a09543148": "intermediate filaments of the cytoskeleton",
    "d4ee2e1fb7364cd6bb5931d72186c5bb": "Desmosomes",
    "e37eef543acc42c0902146dfb8efe1c7": "Bacillus anthracis plasmid pXO1",
    "a206db12420442b69f2caeaf30ae590b": "CO2",
    "2ef046659f484e2c81027f2213ef0759": "pXO1 virulence plasmid",
    "877eabc12fb54287bc30ec4db7f37e8a": "PagR",
    "cf65aa1d62524b4690d8d12f1565be18": "cross - talk",
    "47491f59f6b14de09b72e1a703284430": "host - associated signal",
    "46eb9766357f48e88dcbee645ba193cf": "Rotor syndrome",
    "e677cafc422f4756ba3a515a8090cbb6": "Rotor syndrome",
    "3c81cb4513234032a3bb15f1165ca927": "H19",
    "d00037f6cfab4221bc08a505c4dfabe5": "a subset of extracellular vesicles",
    "b4470440346c4d9faa342aaaeb739017": "anti - IL-17A",
    "4db9416efbb340a49f9352809ab90a84": "IL-17A",
    "c282e77d67224f2583173daa54836108": "interleukin-17A",
    "48fd74acae1f432cb35a1eea0ee94e16": "17A",
    "a40b195dc80a430a92a47b3b524bd7c3": "interleukin-17A",
    "d6448dc3be2e45b2be46a0805cc13200": "interleukin-17A",
    "966b0a95d1b84227ac890a3daaef2086": "cellular adhesion function",
    "918a97ffd8cf4160aebc6fdbfa7df18a": "Interleukin-6",
    "a00c444bb61f44519190db6046039820": "olokizumab",
    "fc6f88c8ca2e451284d7c33fa8b5071a": "STAT3 tyrosine phosphorylation",
    "7a2e176738494125886c80681e52a70e": "IL-6-induced Stat3",
    "3e577b5a3ecf46909b53f1b6b6403b89": "IL-6",
    "a40400d3b6ae46289bee04c76ca63f0d": "C - reactive protein",
    "1e1ef110e6154949bc822e542fff38e2": "serum C - reactive protein levels",
    "d1b0a7f704d04ac5a1e6c189c6c46883": "Interleukin-6",
    "af8f3fdfac2141fb802e6f2ad31ed549": "C - reactive protein concentrations",
    "d7e76d475083479aa3e0f9111bc68897": "Hemoglobin",
    "5cd7ff3ebd7f4aeea91e08b630ebba14": "interleukin-6",
    "0913b9c795bf4b8b9f202745a57d8d03": "MCL-1 , bcl - XL",
    "7887f12a541643aebe9893f82a5f0c28": "Imatinib mesylate",
    "f60b00cd2c9944dc95889093639a4381": "BCR - ABL kinase",
    "da064d93bc6d4d6fa5b680d9a08d7890": "e14a2 BCR - ABL",
    "0bb3119e6d6d48ffa24785cf272e280e": "BCR - ABL tyrosine kinase",
    "fdeaba7b6cb142ef8d135fd8ca5d8c0a": "imatinib",
    "04cb5e56a4624e849a6e56966d0d643e": "Bcr - Abl",
    "3658fa5fcbef4ddbb029ffc40f2d3538": "imatinib",
    "387fa7dc1d984dacbbaa4fab370ed6ed": "Imatinib mesylate",
    "c3ce02b73a0e40788ece57c69b7aafc1": "P210 BCR - ABL",
    "064cad30ab174490b41457be0ef1e8e3": "imatinib mesylate",
    "5900db93e2d94cedaf489326063c2ede": "bcr - abl",
    "e71892e90a214ef1be0a9cb61da4dd09": "TKIs",
    "412a49803a00424099cd84a75d92bd63": "BCR - ABL",
    "86cf7cabdc464986812d7f76361ff136": "oridonin",
    "ec447381a9274cb2925d3a6a913cd81a": "Bcr - Abl",
    "5a0c6d1966e34765aac3aa06d53051c9": "Bcr - Abl",
    "7ab997001a3a4c77a2cb4d78612ac48f": "imatinib mesylate",
    "0c2e363266584674a6c79cd1c7d3e1eb": "Abl",
    "ee2bb6f12fef47d0a3ddeb7d9f328f4d": "BCR - ABL fusion",
    "f00ef1233f084ed28b6eacd36aca14d6": "BCR - ABL",
    "7f2a7d1273d0421f802f06a3bb2fdbbe": "BCR - ABL",
    "8061c24a56e44d69a227a7f6c6c90a8f": "STI571",
    "ed0d438eec964bbe89eb0e88bcc31b14": "STI571",
    "631900f5ead84eacaf274c45701f595a": "BCR - ABL",
    "7a34cd7025714d5fa78883088d8a1b82": "TKI",
    "fd6f4f8657ba4d22a07d09f21a98e576": "BCR - ABL",
    "4039d749db1e402c81b273c51d21f59b": "BCR - ABL",
    "f1bd012a42904b12a152b624439f2533": "Imatinib mesylate",
    "a09775d345e242aba4996ec706515bc0": "TKIs",
    "1db96bcfd90d49b5af28e24058364cb1": "BCR - ABL fusion",
    "9f71ac936fe846a99b99d2e030c881b0": "imatinib",
    "bce2c2d0b05543af83e6b5f57e3ce6da": "dasatinib",
    "34f1609a5e28421ea7ca56e3a8591062": "BCR - ABL",
    "d31cc811c4ed4d9a840643c3c97ec8b6": "Imatinib",
    "07eb57f9a700412681dd07f3b615a303": "Bcr - Abl",
    "5c2cbb8eaf4742919bc8a56682ea0e5a": "Dasatinib",
    "422c039d26e4410290b304947e55dff4": "BCR - ABL",
    "d4a15945d8304a3898c6f391152041af": "Bcr - Abl",
    "ee5c985a3d3b4cd89647bbe76b8def7b": "Bcr - Abl",
    "71db12729a584f868ff6889568d33526": "BCR - ABL kinase",
    "130270c72b1842a69ae47929d7075090": "Imatinib mesylate",
    "ebd82668eb7c49faaf1bd4cce3dd47cb": "Imatinib",
    "097ccc6aa9ba4a0fb9739ed812f2180b": "Bcr - Abl protein",
    "773d0b65b19340d59e18c9cf74fe8c94": "BCR - ABL",
    "513d7255d5544f56ac4e2cdea3c6e3c5": "BCR - ABL",
    "52dc16109e66480083c5d9ca84eb049e": "Imatinib mesylate",
    "169d1ca25e78425dbd60b6192286d3dd": "Imatinib",
    "5d0e918abb8649f49a8cdb096d471c53": "imatinib",
    "11921800c0c14b66b0d48b80283ca54c": "BCR - ABL fusion protein",
    "6a1078ce36c74d609a098b1b566be822": "Imatinib mesylate",
    "0641e4745b234652b621a99faaec9192": "BCR - ABL",
    "ee0fc9bc759e4496ab701a203ebb0a81": "Imatinib mesylate",
    "3cc897405a194e8f95127a9560586a7a": "Bcr - Abl",
    "20881870f0d2416882fd571c09f5bccb": "BCR - ABL",
    "4287f637557a460287055045f9eb49ab": "BCR - ABL",
    "217e551aa17c458399dd0adc87a81d3c": "imatinib mesylate",
    "7eb603c02b0c40579e66fe97ee76c19f": "Bcr - Abl",
    "675a5cb5c500436ea513172bdfcae39c": "imatinib",
    "e19160c7bb354a72b145aeab75882fde": "leukemogenesis in CML",
    "eb81aaa1e4b44724821213505ab1015b": "BCR - ABL",
    "5640bc900f45497f94ba9ba680a9a645": "Imatinib mesylate",
    "b84adc8ad62e42e3b5cd84477d1d0750": "Imatinib mesylate",
    "345ca0bfb3974062abd3ec10a6cbc84a": "TKIs",
    "4fa3e89a79474c9aa77b1afb5c01d09e": "PECAM-1",
    "96ef8f92eb7d4bfe9aab1036cd522d2e": "Imatinib mesylate",
    "daeaeaba2d634317b4b23a5d6051f0e1": "imatinib",
    "88390fb06cb44b229884042b868e9663": "bcr - abl",
    "d9cb4426446f4f91ae4e64614349182c": "ABL tyrosin kinase",
    "1af188b73cef4f9eac8c74a2bb6fc768": "ABL",
    "90bd5d6d1bbd4a51af5bf2328d5aebb7": "Imatinib mesylate",
    "51a1889816af46d0bc6c17f5001e75f4": "Bcr - Abl",
    "fa4fd4baa0d847a58726d0c012409795": "BCr - ABL",
    "6a2e5c9b921c417c892010de2379c6d7": "Imatinib mesylate",
    "29e2e1a616a44ac1921297ac7f7c34c6": "Bcr - Abl",
    "c28f41488c09478c988e4e82f733d188": "ABK resistance",
    "2227001cc02f46f4b3d6c776d15071cd": "methicillin - resistant Staphylococcus aureus",
    "939bd5a155c04ec9b5d6eb9c28071c9d": "Community - associated methicillin resistant Staphylococcus aureus",
    "54d034854e514d05b8be8c343c9d0484": "reduced methicillin - resistant Staphylococcus aureus ( MRSA ) infection rates",
    "eb949241f90c4716aa3b61abe11efb88": "an important nosocomial pathogen",
    "f981f754748548ed8b74416b9b29aedd": "health care - associated",
    "acb2a63cd4e648af8aa61159baa8dc25": "livestock - associated MRSA ( LA - MRSA ) , which is initially associated with livestock",
    "9b31d25da19c48398b26285c6f9b1754": "Methicillin - resistant Staphylococcus aureus",
    "533d5719b67846d886c279b70c0eb6d5": "methicillin - resistant Staphylococcus aureus",
    "ae333a083631463086544ba27a982cf1": "methicillin - resistant Staphylococcus aureus",
    "d763f93b6e6f410da3bf3ba40aa856aa": "14 %",
    "746d6125a1ae4b47b8868da9703ff04b": "negative predictive value",
    "4e1c49bbf28c4f2e9198848bf13a61dc": "methicillin - resistant Staphylococcus aureus",
    "d454454df5fe41c28b4fd7ea8089ab83": "Methicillin - resistant Staphylococcus aureus",
    "4cf67c0ee39c479999455e6a1bb0566a": "clinical therapeutic strategy",
    "aee842a768df4abebce2612c194f1e62": "virulence factors",
    "1a6e6e4476ac4f3694bbf44eba26b5a9": "patients with meticillin - resistant Staphylococcus aureus",
    "77a8e6ff6d4d4b08b5ddf3e5994651eb": "BD GeneOhm Methicillin Resistant Staphylococcus aureus",
    "a9817a6931814cc1929eed39d878021d": "Postoperative methicillin - resistant Staphylococcus aureus",
    "678ea6e0e70c41d294ee49eb162b3e9a": "MRSA infection risk for other patients in hospitals housing large numbers of MRSA - positive patients and/or many patients who were MRSA positive on admission",
    "072774d22d1943ada30195f317483bf3": "whether or not to screen for the presence of methicillin - resistant Staphylococcus aureus",
    "78d3a470a5fc433fb380a0e051deb39c": "methicillin - resistant Staphylococcus aureus",
    "66854406960a4a4ba4cff23625202de8": "fully automated molecular BD Max methicillin - resistant Staphylococcus aureus",
    "b4d2ae32fe78473ead5fbb79a9000745": "more aggressive",
    "0d5291094d50485392d99b2aa3d5c380": "community - associated MRSA ( CA - MRSA ) infection",
    "9acd37ca200b46afa27f75a9f8b082ed": "empirical methicillin resistance",
    "e471eaad8b7f456298a4d3d189d07e9f": "community - onset MRSA infections",
    "3bb7162086024ef8ac8c5df12b9b21a0": "active surveillance efforts to screen for methicillin - resistant Staphylococcus aureus",
    "d121248484f240caaf83cd0a81473232": "clinical isolates of methicillin - resistant Staphylococcus aureus",
    "5b64caa5cdd9442cbac616d39d8d3854": "cross - sectional analytical study",
    "bd18e4066acc45d0970dbce4a776702f": "community - associated",
    "f98dd7a57739471cb2db2af4ebffa125": "Methicillin - resistant Staphylococcus aureus",
    "f4ea9fa4a4b04d9bb9a697ce1418abdb": "methicillin resistant Staphylococcus aureus ( MRSA CC398",
    "f9b282fbb19a4becb10efa8009e39d88": "increased risk of developing surgical site infection",
    "2502a276bbc94f61908c215b2f64ddd4": "92.9 %",
    "0467f41146d14632bf81631eab423b2f": "methicillin - resistant Staphylococcus aureus",
    "8a35ad57cdec42baa86b8aa65906ba8e": "health care - associated",
    "8a4995f43df745ccad6b73c4c7b343ea": "important pathogen of ocular infections",
    "a21e993c7e5d4f7f8143bd59329ed432": "Detection of methicillin ( meticillin)-resistant Staphylococcus aureus colonization",
    "e9f8a67168b34db5ab3343fb3e9136ae": "Methicillin - resistant Staphylococcus aureus",
    "b942fc23c0bf4ebe9bf8e76ac4b3a998": "Methicillin - resistant Staphylococcus aureus",
    "b720f34ec0e14433b46b51f2661ed750": "Methicillin - resistant Staphylococcus aureus",
    "195e202a3f16414ebfc5916fde09ab66": "targeted active surveillance",
    "026a270369604faaa147cd6e84abe86b": "methicillin - resistant Staphylococcus aureus",
    "1f0c6f94bfa249aeaddae73d9c7c9abe": "simple , rapid , and accurate method for performing active surveillance",
    "ffbd79dfefa548019238ea221228221f": "methicillin - resistant Staphylococcus aureus",
    "c8be4f51b2ab4a5381c642b0ef7213c6": "household overcrowding",
    "ceea58daf75a47a2a1f4006fe10ba779": "methicillin ( meticillin)-resistant Staphylococcus aureus",
    "f432b5bc07f54ef7aca42e75d115e658": "flumazenil",
    "6d6de0afbd534ae696a092a6416d4001": "Flumazenil",
    "b4b16d825b304cf98373a45e742826da": "Flumazenil",
    "53789d187e204d27ba5d871adbcd3fd2": "Flumazenil",
    "69f19f12d5914ffbb6a5d62463c20b45": "naloxone hydrochloride should be reserved for patients with signs and symptoms of opioid intoxication . Flumazenil",
    "b31d0f65b3754a4091a4d59b39e2a6a4": "Flumazenil",
    "ebb1ae34a73c4a5d839b1240da0af1a4": "flumazenil",
    "0652e34262bc426d97340af838f8da7e": "Flumazenil",
    "1b2cd22acd744de49a797383cab4fcb4": "Flumazenil",
    "59303c35c98b49d191c1a3ae65d248b9": "flumazenil",
    "6e6cc6752f9047989d4703ae6d6c8051": "flumazenil",
    "f11fbd28f9c1426ebef6f55f607da505": "nordiazepam",
    "4995000228674631b0045fda4996a056": "Flumazenil",
    "0852624d3eb84ea89be6dce27c79703c": "flumazenil",
    "8c08be9367e44a248f7e98941e6d911d": "Flumazenil",
    "09099c4d930143fdb85f846a03675594": "flumazenil",
    "c9a1b2e94527464dbe23ae083f85bd8e": "Flumazenil",
    "369cc5a5643045aebe426287af31c52b": "flumazenil",
    "bdaa9885c8734f2a9a3843206e721bc1": "flumazenil",
    "fc13d80c19934d369960cc64e8a7ed87": "Flumazenil",
    "767ca74416ef41738a08d2aef5208410": "flumazenil",
    "c0676b791a034e7e90ddf7a04c68ddd2": "flumazenil",
    "3a3a4d37044d45888cb523f558ccae65": "Flumazenil",
    "703c26f6e3614fc3ad84fedea34fc7ed": "flumazenil",
    "39e074f0b0694efe8d9c2907bb62096b": "Posterior cruciate ligament",
    "227ac45c39224b96946662810578c154": "posterior cruciate ligament",
    "4ce4a14391204eb893a5d9a49f0652af": "Yersinia pestis",
    "470f42e7c572482a84dd8e9d4a279059": "MDM two binding protein",
    "84e440c52ada4da9ab59b02ebf6421e1": "stroke",
    "87e2ed1c3da9432d8d2e5c5818f3483b": "suspected acute stroke",
    "14137672ed6a4876bd365f25ca43ab63": "suspected stroke",
    "6f0bc4db6f3244efa75413fbbed77285": "acute ischaemic stroke",
    "4499cb8591df4db39618e8fc1992e197": "prehospital stroke",
    "1c541feb2e3d42fa943dbf7eb67303a8": "Stroke",
    "3cd4480a62364a83bc920400cbbe11a2": "suspected acute stroke",
    "25d0a087f52d435dbd25e710f1920dd1": "stroke",
    "382bb11c7a004d7c8c8db92c09fbed6f": "stroke diagnosis",
    "3288fb6fd40c44d78d4fdd8b337240a0": "H3 lysine 4",
    "7f852a929e6a4b24adcfac462afb1477": "trimethylated H3K4",
    "e6d3491bc82b418c870a7d4356305e46": "H3-lysine 4",
    "df4391d3d5f2494faee51e0fa0eb024c": "H3K4",
    "70cf419b833d4e9abc7eac1c6be3673c": "Lys4",
    "76dece4105a44e9e9041be62fc48fbed": "H3K4",
    "795cf9fac2ef407ba53defde51145ed3": "H3K4",
    "f5a528ae5c1742e2a05b03ecd56fb554": "mixed - lineage leukemia 1",
    "66e99ba7d17c47c9b3445238952287b4": "Wdr82",
    "98cb43e4ec95414598cd781412a5d3b8": "H3K4 residues",
    "c52217c869064579a2201e621fdbf60c": "lysine 4",
    "08b59657cf0b4a05a3b821cb53bc7eeb": "skin and connective tissue",
    "b76c8191ad4145ff85301d09427f3538": "NOS3",
    "085511319724479098fd99f2b10f8fe5": "cyclophilin",
    "90bdfabdb48f4ced82219e53d43212a0": "cyclophilin",
    "082b7ea2976047d8b572fd00bfddec04": "delta - distance",
    "4c0b847bbf21420988f6bc921c0b8906": "traseR",
    "a8c3d79c69324f68819dac844e15f438": "Cornelia de Lange syndrome",
    "3edca0aa7f0d4e7fba97191c13e28d28": "Cornelia de Lange syndrome",
    "16c89e69edec4f89b7e12d57432d4b48": "iLIR database",
    "9d3f3ba44ee44d29bc6fd1b262200ffb": "FOXP2",
    "2c0e0f4aa55c4021a72dbdfb12a37f40": "FOXP2",
    "9680c264ad214a85a779948408ae403b": "FOXP2",
    "e6f7d1e34eb24319b5b80ce914ab3c03": "FOXP2 protein",
    "a7027ca777994cbab2cb50fc3cfbf62c": "Transcription factor forkhead box protein P2",
    "7dd09d57cc444e8eb573053076049159": "FOXP2",
    "a5597097671740739398b8d4cab19549": "FOXP2",
    "ea3a586eb5514b869493f732e5740a1c": "Forkhead box protein P2",
    "da08626bddab419dbddfc38db2657996": "intravenous drug abuse",
    "a13f894d41114c86a5a62c07c2b4ee03": "intravenous drug abuse",
    "b303b77c66f64d6c905ec9262e272043": "lymphadenopathy",
    "88fbc5d11e354ff5b7380c243776c918": "Plasmodium spp .",
    "e3479299b8474eb5a5963d6564d7faa9": "Apical membrane antigen 1",
    "72c14e2563a94713baea221bbf150180": "Plasmodium spp",
    "62dfb0f0049641648b339a94e27b7262": "P. vivax",
    "b23f331e696e40feb6adbfbacd5c9d94": "Plasmodium falciparum",
    "1a5db1bc1c094524a9cf3fcac627a7f9": "Plasmodium",
    "edb937b647764c0aa11b371e373061ad": "Plasmodium",
    "4b472a6cb9d048dd9901e39d6b2bb9d0": "Plasmodium species",
    "03a16d0eb3134070ad262ad943d2c738": "P. vivax",
    "1e55c4f1758248f58dd8977c35ab8ead": "HIV",
    "ac9d766d13164566b8388415dae6d5db": "HIV",
    "c3236d984bae4fe9a702753a63371250": "human immunodeficiency virus",
    "8e635a9039f64438813f3959150c7590": "HIV - negative women",
    "a9c0c53d05f1474083e2f1ad8ea28756": "HIV",
    "052d139dea73498a90e500c870e0b52c": "HIV",
    "bf0da804130241878073b33d36565f05": "Human Immunodeficiency Virus",
    "b6d97f2cc9864e81ae3ccfefeac8cedd": "HIV infections",
    "f483c50a36bd44e4b83bf61eb8f5bae9": "HIV-1",
    "10762decaf494889b8a613727b54366b": "localized and disseminated infection",
    "5c077ce1a2b84aa199040b93309cc5b6": "HIV-1",
    "a245513a68e54764b2b701bf8135c90a": "HIV",
    "dc9bceb110f546b884dbdd371fc5a5b9": "HIV",
    "74501bd3f1354fecae7e54e935faa3e9": "HIV-1",
    "34061c30316348ec982b81f03c74200e": "HIV transmission",
    "387330c38e704509996ffc03774c1391": "HIV",
    "47ab244b4b6d4e7191c1323df4d61251": "HIV transmission",
    "f8585ae680a84b258cfa4b315d1378ba": "HIV-1",
    "c83c84f9c33345268a80de699a70104f": "HIV",
    "6e6ede22c58841128c4a2441ff3f34e4": "HIV-1",
    "c1f471c321514f0caf736b5b44d25ecb": "multidrug vaginal microbicide",
    "0d2c4d0d428b4c3ab028752e6ddeb939": "HIV",
    "8c2a0605602f461d93cb146b331734aa": "chaperone - like protein",
    "de1a17e690e849e3a857822511b54678": "decreasing food intake",
    "34c1938371614922aa43c41ab4146049": "psi)RNAs",
    "3b60bd7ce68145749fb65cfe5ee7d2cf": "inhibition of virus or plasmid proliferation",
    "c40581ee9c7a4286b6e7d0e14ece96df": "eukaryotic RNA interference",
    "ba77ea04dbea4db5b99ee41efc509e2d": "CRISPR - Cas system",
    "93b3fce4ac844f3493818175471378b0": "SGLT2",
    "42c9f1c1eae84fa0885493a31db38248": "sodium glucose",
    "4978663209ad4e3098899ad04290262e": "canagliflozin",
    "9c1cec01e81040259bbab2a5f1f03f84": "SGLT2",
    "8e4362d962304849af0e9a9cf344f780": "SGLT2",
    "b276b8fe9b6948f191fb1b8d4d86167a": "canagliflozin",
    "7319749c99d7437480b077f9c67163c7": "macrophage chemoattractant protein-1",
    "1ac6a774b34748d0b2f90a6dd51379eb": "sodium glucose",
    "48dc9bc52067412fa103828ee4ac558d": "SGLT2",
    "32d5c9e48b75450989842a6e97cc6f21": "T2DM",
    "eee52f339cdf4af89a3273019a0da1ab": "SGLT2",
    "95f5fe67a6334781a72627254072209a": "SGLT2",
    "9be314d9fc724bababf59b5df8079c8c": "SGLT2",
    "5cd8e8a3b0244a109179dd5aad4fab3b": "SGLT2",
    "d298832c62de4e73ad3b013ea2443d51": "renal glucose reabsorption",
    "99350de9f10a4165ad5d74c8d6e96534": "SGLT2",
    "b5538b30d15c497e8eafc6e1d38b50cf": "glycosuria",
    "af9599c5e867435a9e2d2a9b430d46b0": "spinal AMs",
    "2ae2864e473745f697faa29712bfb28c": "Grade I meningioma",
    "e876f360fb1c426aaf2c11c8f1ff0327": "convexity meningiomas",
    "8a4e9bb9b22a4d77b479e8ccadb64015": "histology grading was consistent with WHO 2007 classification . The Simpson grading system was used to assess the extent of surgical resection",
    "df74d144994648f89a2af1ac7f36e432": "surgical resection or stereotactic radiosurgery for patients with small- to medium - size intracranial meningiomas",
    "44e178e35d844cdd95994960d939d4dd": "craniotomy",
    "dfc371178f7740ec80686c0baf2ecc3a": "dura mater",
    "b9c0d2a6dfcf4b40ba4c7b65373f1159": "seven",
    "4d0d8f548cf94dc489db689b3aa53512": "two",
    "4ac4c382940b442db8c27a8b57de6f0e": "crowding - induced liquid / liquid phase separation",
    "f40c5ca38b964c3fbfd353444320a3b9": "41 out of 48",
    "88146ec6149e4c6ea96cd35e52672e06": "48",
    "34689931e2824bf58d7aa234d7a4eed3": "48",
    "2b04e73544f7459d9232316ec0e13a4a": "programmed death receptor-1",
    "78f0c50b8c6849b2859237d4e919f8cd": "pembrolizumab",
    "900bfac64b0f4a6b8c03e872ceb0fbf1": "RNA polymerase II",
    "7e8e0ce5314a41af8717ec9140ab7049": "RNA polymerase II",
    "800083a0aff44406b0a95cb46cf7343b": "RNA Polymerase II",
    "a71bfab3e52a453389459997d51e71f2": "RNA polymerase II",
    "354a06365eb5430db7d04eb6bea5af55": "RNA polymerase II",
    "f8691bdd04254433a162cdef7998689e": "RNA polymerase II",
    "1d7bdd75c990481ca677c46e2eb7a4db": "RNA polymerase II",
    "cc8c050eacbc476399b7a6d1ccc9c404": "RNA polymerase II",
    "a58fef1200654b849fbfc54e893e1678": "long RNA polymerase II primary transcripts",
    "8e8bc2fb6f4f494c94d828de7c279203": "RNA polymerase II inhibitor , alpha - amanitin",
    "d5012159612c4b0b9722b00581b7cf34": "RNA polymerase II",
    "0d62867611e34119b3f038886614e0ab": "RNA polymerase II",
    "cdd96acd2fc94e268b146391bc401383": "RNA polymerase II",
    "bfbcb1b432584aff8df5bc3c70e56f62": "RNA polymerase II",
    "9bb5d9f90f804b34971f0a239f63343b": "PCR - targeted disruption",
    "5af94115175949a3aa6007921a11d0a1": "increased LAP / ACP2 protein expression in CLN3-deficient cells",
    "4a70e96cd685482787d78a9a40f450ca": "To elucidate the biosynthesis and localization",
    "3dc4e3f9a1154fac800afd66066ee701": "CLN3 defect in juvenile Batten disease may affect how intracellular levels of arginine are regulated or distributed throughout the cell",
    "4a7fcf0ca992473da095fa4ba3f4fffa": "Overexpression of this gene increases survival of human NT2 neuronal precursor cells",
    "8a6acd5fd68e49d2b775304d9aef5eb9": "anti - neuronal death function",
    "6d7b3c37d90b4259923fc6b4defc1056": "synaptic vesicle transport / transmission",
    "bb74435049ca4f75a40f7eeaf2c5dd00": "localizes to the vacuole",
    "1c5db62efbc145768b9fd53df6a404d5": "increased expression",
    "33398486efbc4a99900b44a64f12568d": "in vitro",
    "f4dbacd4b84947bea18cfff2673de042": "UCP1 + adipocytes",
    "7d3d225c01ba4d0daa3bfa2341e0caf8": "calcium / calmodulin - dependent protein kinase II",
    "09c09f04d62340e7a2d99bac736f71ae": "CaM kinase II",
    "b747f9b082a644009fdd2023df633b19": "Ca2+/calmodulin - dependent protein kinase II",
    "85429e012dfa4820827bfe31697d7c1d": "phosphatidylinositol 3-kinase",
    "f06d0fa0fbbc473f94d4d0b3591a5676": "CaM kinase II",
    "4c1e2ae7b3044ebdbc54ebb2645c4732": "MAP kinase and CaM kinase II",
    "ffa61ee66681406ea24f30171ebbc713": "MDR - TB",
    "e7dd43f614bd4a44808e13eb2dbde1f6": "XDR - TB",
    "cffa38bb217641c08713c8debdecf88f": "Mycobacterium tuberculosis",
    "70def1204d7c4c8eacdf2cc36356ec55": "arrhythmia",
    "9dd06b2102304cdc8188c97c503ffb35": "multidrug - resistant tuberculosis",
    "7cb5e988b4514ab3944739cfd8b67239": "pneumonic anthrax",
    "1a0f88859ac041309e802081a92d69d7": "SMIM1",
    "b09a032cfe6b458dad0480594898b130": "McLeod",
    "2a7364668d534661a202c2f541df1621": "XK",
    "5fd7a2dfb5344090b95d6ffff8d1456c": "XK",
    "f252703de7194f1983547f4bf860ba40": "XK gene",
    "0574b68d8a1845829336d0bb8c46aef6": "CED-8",
    "4678fd2baf4f4fc2a3d6a5f6d70178ed": "XK",
    "7188c1bd11be428bab87e000b19fdf3b": "XK gene on the X - chromosome . We present six males ( aged 29 to 60 years ) , with proven XK",
    "e6169de72a8e46a8bfd4b79a1daa5dc7": "XK",
    "22c0308943bd43cc8df2cab2658af54e": "XK",
    "b5b0517d354847768bfb0266b7052a80": "XK",
    "30982bbba290475cadfbcc0116b0d9c4": "XK gene",
    "c79bc1f8f85548358708cf9eb729f140": "XK gene",
    "363dd52c30bd4c8b98c0e42bbe9d8ce1": "VPS13A and XK",
    "d1447b95f9f34df4bd86e6dafa47596b": "XK",
    "8f600aec47fb4b109b628824fc85d81f": "XK",
    "abc48333075f4fbd8c6a3a5ac4b684a2": "XK gene",
    "d82fcc5243f04463a79983358c686ff9": "XK",
    "301ef4187543422199ccbb4addc1483d": "XK gene",
    "e472df4a59ae4903a88c41fd0f454190": "X - linked CYBB gene",
    "2f7b7e71153e42089cfb1ba8aff9bd9e": "XK gene",
    "c44de3a52803425c8e515bdb5fb039ac": "XK",
    "9019bb534c7b4632b5c84114049ce836": "E327 K missense",
    "2dd00a7d6c44433e8886712abfe64730": "XK",
    "682f059c5e1247ec92d678ce3cc5a4cc": "XK gene",
    "709fee36b5e44977bdf24dd072d08608": "XK",
    "ae5bb34ab378486298ab61b3973ece7b": "XK gene had a point mutation in the donor splice site of intron 1",
    "7ff12940e9c34f73936d58aa6f5f4f8b": "XK",
    "f9dd23b8836640968364324126b3087b": "Alzheimer 's disease",
    "b8293e4bcc944de3949762790d040d05": "Alzheimer 's disease",
    "cded98aedc6a494e8a1a1d00dd9f85aa": "Alzheimer 's disease",
    "9e28aa040a2f43c3ab63eeba84b5f4de": "Alzheimer 's disease",
    "f0957846c2644cfea2237b83f75706a6": "APP / V717I",
    "7f2e06512c64492fae5b7778eda5946f": "Alzheimer 's disease",
    "359b351dab714a9eb679ec9eef3d8227": "double Swedish / London mutation",
    "4bf55f1486ae40eeb5ec072729959f4a": "Alzheimer 's disease",
    "c6a3fb62d44040b1a6fe442b2aadc722": "Alzheimer 's disease",
    "32973e8f67554664bd82736f4b992923": "familial Alzheimer 's disease",
    "b1ad29199ed6423184843a3ceb0c058c": "V717I",
    "8060a2992f724000a8c3de198bfabc09": "APP751",
    "a55e414441024908948b22932972e090": "Alzheimer 's disease",
    "fd787f32d19848dbb65fe34c00222562": "Alzheimer 's disease",
    "67266c29b6f5450a9294e9b1d43aa376": "Alzheimer 's disease",
    "2e818059dd7c4f0d898f3266677d9a3c": "Pathogenic",
    "09c00290afa34b8c9b894ac93f398090": "Alzheimer 's disease",
    "d8237f9d763b42d483bb971b70dd1706": "Alzheimer 's disease",
    "34f812a7bd0645b481c7269f56ee725d": "JAMM",
    "91db4f5a6e754a4889b60c8eb22bc009": "stationary",
    "ec31bfcdb41d4c6f9c960d1d6c2dbf2c": "stationary",
    "1126a2a0c1ae4863844e2b5cc811f042": "stationary",
    "1daf44d1e59d499da16d3746bd6277c2": "stationary - phase",
    "2a963d7335cb4cfa9452f4ded58a357f": "nestin",
    "2c9f3d096d9b474e81e534d2b2027f2b": "Bcl-2",
    "2955684affa14660b9c3b54689b9b2d2": "nestin",
    "030fff89fcaf4f7a8d31056a6f48f949": "nestin",
    "5545d0766eda451eb3ef4f3e3ac2706e": "vimentin",
    "69369bb8e0cf4025bff67e3552f85dad": "glial fibrillary acidic protein",
    "36dc5cbeedc44c65ab77495e3f481e0d": "Nestin",
    "1f13212b55544ebc9031055963334233": "eGFP",
    "93550bd7ff2742e5be0946f9e56d9da7": "piglet NSPs",
    "e071020dd038420e9fd5fc750ec99bbe": "5-bromo-2'-deoxyuridine",
    "71a8f4bdfee54f928c7a8b69ef3ca448": "nestin , Musashi-1 ) and differentiated cells ( glial fibrillary acidic protein",
    "6cc9877ac4fc485b8865be0daa1ae5a3": "Prominin-1",
    "ab3ff6a5a146419f8fd61b433587067c": "nestin",
    "d35038567c084610981eef4ef2010504": "nestin",
    "9bbe9aa6979c41d589172404e634acc1": "Cu / Zn superoxide dismutase",
    "37ea67d513cc47e680a8cad150662beb": "dabigatran , in a mouse model of OAC - ICH . Dabigatran etexilate",
    "8dfe7776209f42c6b08aeb043f1ac872": "andexanet , and PER977",
    "34511ff99544417f936dc6f115803c07": "dabigatran",
    "88499aa29e45416bba7bf6cc24031571": "dabigatran",
    "6f46d726a7c249e68c5a8726f672c870": "Pse - in - One",
    "f8aa034423ce4cffb22a4a551f8ad7f6": "bone metabolism",
    "0029838703954d16a57a5cc158fd86d5": "bone metabolism",
    "ba738d6a94a647e9b9d8ac77b74a34a3": "bone metabolism",
    "c769d26d6d6e49a8bccbfa8ca3020245": "bone metabolism",
    "8975f12eced24dab8b0c41383c7ba4d8": "miR-138",
    "aac69dde3c754b6ab56366207d37f1f7": "circRNA , sex - determining region Y",
    "71b0e329f10047c39ece3b5149f7ae9c": "miR-138",
    "6e72346d9baf4bee8b690349f4e87241": "naloxone",
    "00d9954d30b64647a55f59618756c1ce": "naloxone",
    "70d7878277804532b313a72e5e20e286": "naloxone",
    "bbac40c6eb3c41cd806dbc42ad8f54dc": "naloxone",
    "bb05ffd715264fdf8fc2a8c7edaf0d04": "naloxone",
    "68e4445ef5d34c65bd2ec1725352e5b2": "naloxone",
    "ebd0c01ec7c04fefaecf5b72360eeaba": "the SECIS element",
    "3624d6c1965c47c49133ffb4a885552b": "Sec insertion sequence ( SECIS ) element",
    "22a6d5d4fcc740a0998d3d943187fa60": "SECIS elements",
    "414be8e3552c4a35af6a2803ffbea6d7": "The Sec insertion sequence ( SECIS ) element",
    "8588c6a6d2b34d4ba7cbf44f2320db4d": "selenocysteine insertion sequence",
    "03e383d3bf6142a5983cf58fc309b81d": "stem - loops",
    "4a2ea59ce04b469fb5deddf4edb5b587": "selenocysteine insertion sequence",
    "0d37ab3d489b4d7da2bc133cfa75a2d3": "Sec insertion sequence ( SECIS )",
    "0c52975c66384d66a1af964bd53fdfc5": "Sec insertion sequence element",
    "c74fb4970f0c433ca0ed2902b475918f": "UGA codon",
    "b3180bd2a2c74801ad23a33210e43134": "hairpin",
    "c974d3fb68c64a29b1b191a9eb7f8eec": "selenocysteine",
    "00475180d274498e9dad745b5ff8c048": "SElenoCysteine Insertion Sequence",
    "22db25e825ff4bcfb783e89d2d7a8162": "selenocysteine insertion sequence",
    "8708371a1d3b41c89c378772ccbe6fb2": "SECIS element",
    "0a4156b343cd4fec9fc3e8a4b0331052": "selenocysteine insertion sequence ( SECIS ) element",
    "1c6613dd665f492bbe1abcd1251441b6": "SEC incorporation sequence ( SECIS",
    "60845a786b424b11bfedd9ec58170947": "SECIS ) element",
    "5798e357ab44416ea1ecd5323e3e7ae4": "SECIS elements",
    "a90edaed7fbb4491a6476503ca82d435": "proximal stem - loop",
    "0dbd2d5ca0924a50a3508f121aec86a6": "SECIS element",
    "0d1597667c614526ba0ceede9a3ecc54": "selenocysteine insertion sequence ( SECIS ) element",
    "3fe09fafae1c4200bf36faea155c3c62": "helix II",
    "97cb4d97afcb4eb2952fd63b3de90dbf": "BCR - ABL fusion",
    "85a18e64fb2d47b0afeee4832c599891": "BCR / ABL gene",
    "6d9bef92c6174aa29bde5d03ae2f5809": "BCR / ABL",
    "1d0edfd264d5465fadb7c6268c608128": "BCR - ABL",
    "5bccb35d6e25413884c6d89ff4623553": "BCR - ABL",
    "b60b5fefa0974ab9bf4f02ae03d69a4c": "BCR - ABL gene fusion",
    "bab3517808284dd78fb78dee6116e087": "AML1-EVI1",
    "efad110a71da44ecb9d4f661d22b9692": "BCR / ABL",
    "0e334455b93e49ba8dc2280657d82443": "craniosynostosis and marfanoid",
    "78c142601b5048dd9ab83e39d4e8e15f": "craniosynostosis",
    "31b5228a9b2e43878afead6abaf040d4": "frontometaphyseal dysplasia",
    "9038f03f7233434d94806443d485149a": "TGFBR2",
    "3dfda990261e42298551bc5ea767d706": "Shprintzen - Goldberg syndrome",
    "0d848258b8d84a2a99aa7452c73c0752": "congenital weakness of the abdominal wall",
    "07d30350f8434b48815eaa39fc6cedd9": "thin body habitus",
    "2406a794568840628014804927e40975": "hypotonia",
    "b0c5cb7e458c48f9a369b023a6f154ef": "prion",
    "1f9ba193c3004e76bc6c7b235f7af430": "four",
    "89d94b385eb34bc8ba92ccfb2605442f": "alpha - synuclein",
    "6bb8ed04d3334d21be1d6007dec1ca83": "GCIs",
    "838f259cf3d94ed1a4628e26a79fa183": "phosphorylated alpha - synuclein",
    "65a878a609f441afbfab92ba3203df80": "alpha - synuclein",
    "2a5f33eb024e41f39c9afc6c4409b13a": "alpha - synuclein and tau",
    "0d833841a938438ba27b155f675edff5": "alphaS",
    "657d5d7eecf249cb96e36f5b3a818fcf": "alpha - Synuclein",
    "9b932296712649baab2d48f9496ce387": "alpha - synuclein",
    "2c9a3ae9437648e1834a87d46d29cd29": "alpha - synuclein",
    "3005311091144dfdb1464aeae598c703": "PSer129",
    "d3600ecb55744469b54fde10d8d1c38e": "NAC",
    "85b37fa6f6cb4803bcf4aa988b62bbac": "tau",
    "4a2d924caf4d464aa5a7837b4e6e320d": "alpha - synuclein",
    "6ca2123e52db4eabb7129fcdd9ffb251": "hypermobile urethra",
    "bc7735fd4a4446a7a5c1378082daf71f": "transient urinary retention",
    "810e979286e64a7eac73389457ab5f2c": "SUI",
    "697de39cc87343798ea51f9debbc2c55": "stress",
    "aee1887f35d54a65b4bb576170e07197": "stress",
    "804f275edde947989343c29d6110428e": "urethral hypermobility",
    "73a1a36fb91449d6a4ac7d06dcdee186": "female stress",
    "7612f12628274b6dbdc14d2f9a22855f": "stress",
    "73c2cde9b4664d44a29664bb0b7cb086": "mySQL",
    "59b8dc15064f45a0b670dacf91a6101a": "mechanisms of spliceosome function",
    "b57cadd16f7a4c1795c6018b46b69e57": "intravenous placebo",
    "341ad31d93c34ba196d196dbeca4aa12": "increase stillbirths and infant mortality",
    "ccb9b1d3df6f45b2bb19557def943330": "chronic pain",
    "220f2fda6f7b4ca1a8b1ce1ca1c93bb3": "chronic pain",
    "a1677a4677f04576b7808123469477f1": "osteoarthritis ( OA ) and low back pain",
    "702ca078e3664e4f8f2e876395b0f7d4": "NGF epitope",
    "fca52edd5cb744269b2e262e1328a554": "Nerve growth factor",
    "6f76097048934cc28e54c79c8ca57345": "inhibition of the TrkA pathway in pain",
    "589de266ea4f4f239030a2ea5f61bf8b": "osteoarthritis",
    "6039fcd253ac44cb9e8813354f3d424a": "moderate to severe osteoarthritis",
    "e516230f0c0040adab7360b90e76c7e0": "interstitial cystitis pain",
    "50ae8202b2234d05a6012bace0a32fa7": "rats",
    "3839284ce858430f8f66e799ad122c16": "\u03b2 - nerve growth factor",
    "6646e3f641a345e690d62f36d4d47765": "NSAIDs and opioids",
    "5e08c43eb8b64887bf868e17d62cc5c8": "NGF pathway",
    "325680c55d7146c69a2cdebde92b66df": "neutralization in chronic pain syndromes",
    "9345b19e2b08406092884e3a093f3bd3": "NGF",
    "53453018272b4cbaa4e322487a25246c": "to treat pain and other symptoms of chronic prostatitis / chronic pelvic pain syndrome",
    "24a13e3726da44deb5ad15627d9c04f8": "nerve growth factor and reduces chronic pain",
    "2ab00371c0644e0ca45158c35d6dbf8e": "pain relief of low back pain",
    "cf8660626db24842b789111d454df139": "nerve growth factor",
    "8d8314284e3742b58233aac35847fb78": "nerve growth factor",
    "75cf86f198b54282922a9737923ac9a6": "neuropathic pain"
}
